CN107449906A - A kind of paper chromatography chemical luminescence detection method - Google Patents
A kind of paper chromatography chemical luminescence detection method Download PDFInfo
- Publication number
- CN107449906A CN107449906A CN201610373048.6A CN201610373048A CN107449906A CN 107449906 A CN107449906 A CN 107449906A CN 201610373048 A CN201610373048 A CN 201610373048A CN 107449906 A CN107449906 A CN 107449906A
- Authority
- CN
- China
- Prior art keywords
- thing
- checked
- immobilon
- compound
- junction mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/76—Chemiluminescence; Bioluminescence
- G01N21/763—Bioluminescence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Plasma & Fusion (AREA)
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
Abstract
The invention discloses a kind of chemiluminescence detection combined complete and detection method, include thing specificity junction mixture, particulate, immobilon-p, chemiluminescent reactant, centrifugal device and luminescence detector to be checked, wherein described chemiluminescent reactant includes chemiluminescence enzyme, chemiluminescent substance, chemiluminescence enzyme reaction substrate and starts at least one of luminescence reagent;The particulate is directly and/or can form non-specific binding by the mode of being chemically crosslinked and protein and/or the chemiluminescent reactant and maintain stable particle;The immobilon-p is with the film quality material with protein non-specific binding characteristic;The centrifugal device is the structure that can centrifuge driving liquid phase chromatographic flow on the immobilon-p;The thing specificity junction mixture to be checked is at least one of antigen with specific binding capacity, antibody, Avidin, biotin and the like.The present invention has the characteristics of high sensitivity, detection time is short, has a good application prospect.
Description
Technical field
The present invention relates to a kind of paper chromatography chemical luminescence detection method, belong to technical field of immunoassay.
Background technology
Immunology detection technology is measure antigen, antibody, immunocyte and the chemical composition of applied immunology principle design
Deng laboratory facilities, the sample of medical diagnosis on disease and health detection can be carried out from human body and animal body and be used for by being widely used in
Environment, Pharmaceutical Analysis, food and the sample of Industrial Analysis.Conventional has immune turbidity technology, solid-phase enzyme immunoassay technology, changes
Learn luminescent detection techniques, immunofluorescence label technology, flow cytometry, colloidal gold technique etc..Immune turbidity technology, it is also referred to as immune
Nephelometry is soluble antigen, antibody specific bond in the liquid phase, produces a certain size compound, forms the refraction or suction of light
Receive, determine the transmitted light after this refraction or absorption or scattering light as unit of account, for quantitatively detecting, but detection sensitivity
It is low, it is not suitable for trace detection.The enzyme of immobilization and antigen or antibody of the solid-phase enzyme immunoassay technology based on antigen or antibody
Mark, is incorporated in the antigen of surface of solid phase carriers or antibody keeps its immunologic competence, and the enzyme conjugates of antigen or antibody was both protected
Its immunologic competence is stayed, retains the activity of enzyme again, in measure, by inspection sample(Determine antibody or antigen therein)With enzyme mark
Antigen or antibody react by the antigen or antibody of different step and surface of solid phase carriers, have high sensitivity, linear response
The remarkable advantages such as scope is wide and easy to automate, but detect reaction time length and limit its use.Immunochemiluminescence is examined
Survey technology is a kind of highly sensitive micro and Analytical Methods of Trace, have easy to operate, high sensitivity, linear response range wide and
It is easy to automate to wait remarkable advantage, it is widely used in environment, clinic, Pharmaceutical Analysis, food and Industrial Analysis, and
The luminescence reagent labelling technique of solid phase separation means and antigen or antibody based on antigen or antibody, but detect the reaction time it is long and
Requirement height on detection device also influences its use.Immunofluorescence label technology, flow cytometry, colloidal gold technique are also conventional
Detection technique be widely used, but have its corresponding deficiency, the detection reaction time is long or sensitivity, accuracy shortcoming are general
All over existing deficiency.High sensitivity, quick, miniaturization, quantitative, automation is the hair of current clinical immunization detection technique product entirely
Exhibition trend, but existing above-mentioned function can not be all realized simultaneously.
The content of the invention
It is an object of the invention to provide a kind of paper chromatography chemical luminescence detection method.The present invention has high sensitivity, detection
The characteristics of time is short, the detection range of linearity is wide, easy to use.
A kind of paper chromatography chemiluminescence detection combined complete provided by the invention, is characterised by, the detection combination suit
Containing thing specificity junction mixture, particulate, immobilon-p, chemiluminescent reactant, centrifugal device and luminescence detector to be checked, wherein
Described chemiluminescent reactant includes chemiluminescence enzyme, chemiluminescent substance, chemiluminescence enzyme reaction substrate and started luminous
At least one of reagent;The particulate is directly and/or can pass through the mode of being chemically crosslinked and protein and/or the chemistry
Luminescence-producing reaction thing forms non-specific binding and maintains stable particle;The immobilon-p be with protein non-specific knot
Close the film quality material of characteristic;The centrifugal device is the structure that can centrifuge driving liquid phase chromatographic flow on the immobilon-p;
The thing specificity junction mixture to be checked is the antigen with specific binding capacity, antibody, Avidin, biotin and the like
At least one of.
The detection method that detection combination described in a kind of claim 1 is set with, it is characterised in that:The detection method is as follows
(A)-(F)In it is any:
(A)Comprise the following steps:
1)The particulate is marked with the thing specificity junction mixture to be checked and the chemiluminescence enzyme simultaneously;
2)Reacted with the particulate after the sample containing thing to be checked and the mark, the thing to be checked by with after the mark
Particulate on the thing specificity junction mixture to be checked combine, and then form " chemiluminescence enzyme-particulate-thing to be checked specificity knot
Compound-thing to be checked " compound, i.e. compound 1;
3)Coating can be treated by forming the second of specific binding with the thing to be checked on compound 1 on the immobilon-p
Examine thing specificity junction mixture;
4)With the liquid phase containing the compound 1, by chromatography, to flow through coated second thing to be checked on the immobilon-p special
Property conjugate, form " chemiluminescence enzyme-particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing to be checked specific binding
Thing " compound, i.e. compound 2, and be captured and be fixed on the immobilon-p;
5)Using centrifugal chromatography, cleaned with cleaning fluid described in the compound 1 being not associated with the immobilon-p and residual
Chemiluminescence enzyme;
6)The immobilon-p after cleaning is placed in the chemiluminescence enzyme reaction substrate liquid and reacted, and with the luminous detection
Chemiluminescence enzyme reaction substrate described in the chemiluminescence enzymatic that device detection is indirectly fixed on the immobilon-p produces
Luminous value, to detect the content of the thing to be checked;
(B)Comprise the following steps:
1)The particulate described in the thing specific binding substance markers to be checked;
2)The specificity junction mixture of the thing specificity junction mixture to be checked is marked with the chemiluminescence enzyme, forms " chemiluminescence
The specificity junction mixture of enzyme-thing to be checked specificity junction mixture ", i.e. chemiluminescence enzyme marker;
3)Reacted with the particulate after the sample containing thing to be checked and the mark, the thing to be checked by with after the mark
Particulate on the thing specificity junction mixture to be checked combine, and then form " particulate-thing to be checked specificity junction mixture-thing to be checked "
Compound, i.e. compound 3;
4)The described second thing specificity junction mixture to be checked is coated with the immobilon-p;
5)With the liquid phase containing the compound 3, by chromatography, to flow through coated second thing to be checked on the immobilon-p special
Property conjugate, formed " particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing specificity junction mixture to be checked " compound, i.e.,
Compound 4, and be captured and be fixed on the immobilon-p;
6)With the liquid phase containing the chemiluminescence enzyme marker by chromatography flow through be trapped in it is compound on the immobilon-p
Thing 4, by being combined with the thing specificity junction mixture to be checked, formed " the chemiluminescence enzyme marker-compound of compound 4 ", i.e.,
Compound 5, and be captured and be fixed on the immobilon-p;
6)Using centrifugal chromatography, the chemiluminescence enzyme marker that is not associated with the immobilon-p and residual is cleaned with cleaning fluid
The chemiluminescence enzyme stayed;
7)The immobilon-p after cleaning is placed in the chemiluminescence enzyme reaction substrate liquid and reacted, and with the luminous detection
The chemiluminescence enzyme reaction substrate described in the chemiluminescence enzymatic that device detection is indirectly fixed on the immobilon-p
Caused luminous value, to detect the content of the thing to be checked;
(C)Comprise the following steps:
1)The particulate is marked with the thing specificity junction mixture to be checked and the chemiluminescence enzyme simultaneously;
2)Reacted with the particulate after the sample containing thing to be checked and the mark, the thing to be checked by with after the mark
Particulate on the thing specificity junction mixture to be checked combine, the thing to be checked by with the thing specificity junction mixture knot to be checked
Close, and then form " chemiluminescence enzyme-particulate-thing to be checked specificity junction mixture-thing to be checked " compound, i.e., described compound 1;
3)The second thing specificity junction mixture to be checked is marked with intermediate material A;
4)Coating can form the intermediate material B of specific binding with the intermediate material A on the immobilon-p;
5)The the second thing specificity junction mixture to be checked marked with the liquid phase containing the compound 1 with the intermediate material A is carried out
Reaction, formed " chemiluminescence enzyme-particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing specificity junction mixture to be checked-in
Between substance A " compound, i.e. compound 6;
6)The coated intermediate material B on the immobilon-p is flowed through by chromatography with the liquid phase containing the compound 6, formed
" chemiluminescence enzyme-particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing specificity junction mixture-intermediate material A- to be checked
Intermediate material B " compounds, i.e. compound 7, and be captured and be fixed on the immobilon-p;
7)Using centrifugal chromatography, cleaned with cleaning fluid described in the compound 6 being not associated with the immobilon-p and residual
Chemiluminescence enzyme;
8)The immobilon-p after cleaning is placed in the chemiluminescence enzyme reaction substrate liquid and reacted, and with the luminous detection
Chemiluminescence enzyme reaction substrate described in the chemiluminescence enzymatic that device detection is indirectly fixed on the immobilon-p produces
Luminous value, to detect the content of the thing to be checked;
(D)Comprise the following steps:
1)The particulate described in the thing specific binding substance markers to be checked;
2)The specificity junction mixture of the thing specificity junction mixture to be checked is marked with the chemiluminescence enzyme, forms " chemiluminescence
The specificity junction mixture of enzyme-thing to be checked specificity junction mixture ", i.e., described chemiluminescence enzyme marker;
3)Reacted with the particulate after the sample containing thing to be checked and the mark, the thing to be checked by with after the mark
Particulate on the thing specificity junction mixture to be checked combine, and then form " particulate-thing to be checked specificity junction mixture-thing to be checked "
Compound, i.e., described compound 3;
4)The second thing specificity junction mixture to be checked is marked with the intermediate material A;
5)Coating can form the intermediate material B of specific binding with the intermediate material A on the immobilon-p;
6)Reacted with the second thing specificity junction mixture to be checked of the liquid phase containing the compound 3 and intermediate material A marks,
Formed " particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing specificity junction mixture to be checked-intermediate material A " compounds,
That is compound 8;
7)The coated intermediate material B on the immobilon-p is flowed through by chromatography with the liquid phase containing the compound 8, formed
" particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing specificity junction mixture to be checked-intermediate material A- intermediate materials B " is multiple
Compound, i.e. compound 9, and be captured and be fixed on the immobilon-p;
8)With the liquid phase containing the chemiluminescence enzyme marker by chromatography flow through be trapped in it is compound on the immobilon-p
Thing 9, by being combined with thing specificity junction mixture to be checked, form " the specificity knot of chemiluminescence enzyme-thing to be checked specificity junction mixture
Compound-the compound of compound 9 ", i.e. compound 10, and be captured and be fixed on the immobilon-p;
9)Using centrifugal chromatography, the chemiluminescence enzyme marker that is not associated with the immobilon-p and residual is cleaned with cleaning fluid
The chemiluminescence enzyme stayed;
10)The immobilon-p after cleaning is placed in chemiluminescence enzyme reaction substrate liquid and reacted, and with the luminescence detector
Detect and lighted caused by chemiluminescence enzyme reaction substrate described in the chemiluminescence enzymatic being indirectly fixed on the immobilon-p
Value, to detect the content of the thing to be checked;
(E)Comprise the following steps:
1)The thing specificity junction mixture to be checked and chemiluminescent substance mark are connected on the particulate;
2)Reacted with the particulate after the sample containing thing to be checked and the mark, the thing to be checked by with after the mark
Particulate on the thing specificity junction mixture to be checked combine, and then form " chemiluminescent substance-particulate-thing to be checked specificity
Conjugate-thing to be checked " compound, i.e. compound 11;
3)The second thing specificity junction mixture to be checked is coated with the immobilon-p;
4)The coated second thing spy to be checked on the immobilon-p is flowed through by chromatography with the liquid phase containing the compound 11
Specific binding agent, form " chemiluminescent substance-particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing specificity to be checked
Conjugate " compound, i.e. compound 12, and be captured and be fixed on the immobilon-p;
5)Using centrifugal chromatography, described in cleaning fluid cleans the compound 11 being not associated with the immobilon-p and residual
Chemiluminescent substance;
6)The immobilon-p after cleaning is placed in the starting luminescence reagent solution and reacted, and is examined with the luminescence detector
Luminous value caused by the chemiluminescent substance decomposition being indirectly fixed on the immobilon-p is surveyed, to detect the thing to be checked
Content;
(F)Comprise the following steps:
1)The particulate described in the thing specific binding substance markers to be checked;
2)The specificity junction mixture of the thing specificity junction mixture to be checked is marked with the chemiluminescent substance, forms " chemistry hair
The specificity junction mixture of stimulative substance-thing to be checked specificity junction mixture ", i.e. chemiluminescent substance label;
3)Reacted with the particulate after the sample containing thing to be checked and the mark, the thing to be checked by with after the mark
Particulate on the thing specificity junction mixture to be checked combine, and then form " particulate-thing to be checked specificity junction mixture-thing to be checked "
Compound, i.e., described compound 3;
4)The second thing specificity junction mixture to be checked is coated with the immobilon-p;
5)With the liquid phase containing the compound 3, by chromatography, to flow through coated second thing to be checked on the immobilon-p special
Property conjugate, formed " particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing specificity junction mixture to be checked " compound, i.e.,
The compound 4, and be captured and be fixed on the immobilon-p;
6)With the liquid phase containing chemiluminescent substance label by chromatography flow through be trapped in it is described multiple on the immobilon-p
Compound 4, by being combined with the thing specificity junction mixture to be checked, form " chemiluminescent substance-thing to be checked specificity junction mixture
Specificity junction mixture-the compound of compound 4 ", i.e. compound 13, and be captured and be fixed on the immobilon-p;
6)Using centrifugal chromatography, cleaned with cleaning fluid the chemiluminescent substance label that is not associated with the immobilon-p and
The chemiluminescent substance of residual;
7)The immobilon-p after cleaning is placed in the starting luminescence reagent and reacted, and quilt is detected with the luminescence detector
Luminous value caused by the chemiluminescent substance decomposition on the immobilon-p is indirectly fixed to, to detect the content of the thing to be checked.
In above-mentioned paper chromatography chemical luminescence detection method, the intermediate material is anti-with specific binding capacity
At least one of original, antibody, Avidin, biotin and the like.
It is described to chromatograph the reaction for flowing through the immobilon-p in centrifugation dress in above-mentioned paper chromatography chemical luminescence detection method
Put and complete and using centrifugal chromatography driving liquid chromatographic flow on immobilon-p.
In above-mentioned paper chromatography chemiluminescence detection combined complete or detection method, the particle diameter of particulate selection 1nm ~
10um, concretely 10 ~ 3000 nm, 20 ~ 2000 nm or 43 ~ 1000 nm.The particulate is can directly and/or passing through
Crosslinking method is learned to form non-specific binding with protein and/or the chemiluminescent reactant and maintain stable particle, mesh
Preceding conventional particulate have colloidal gold particles, colloidal selenium particles, colloid gold-magnetic particles, fluorescent microsphere, magnetic particle, gold-magnetic particles,
Microgel particle, emulsion particle, plastic microsphere, microsphere silica gel, agarose beads, ps particle, silicon dioxide microsphere, polyphenyl
Ethene microballoon, carboxyl microballoon, chloromethyl microballoon etc..
In above-mentioned paper chromatography chemiluminescence detection combined complete, the rotating speed of the centrifugal device uses programme-control side
Formula;The rotating speed of the centrifugal device is 200 ~ 10000 revs/min, concretely 500 ~ 5000 revs/min, 800 ~ 3000
Rev/min or 800 ~ 2000 revs/min.
In above-mentioned paper chromatography chemical luminescence detection method, the rotating speed of the centrifugal chromatography uses program controlled mode;
The rotating speed of the centrichromatography is 200 ~ 10000 revs/min, concretely 500 ~ 5000 revs/min, 800 ~ 3000 revs/min
Clock or 800 ~ 2000 revs/min.
In above-mentioned paper chromatography chemiluminescence detection combined complete or detection method, the chemiluminescence enzyme includes horseradish mistake
At least one of oxidizing ferment, alkaline phosphatase and xanthine oxidase.
In above-mentioned paper chromatography chemiluminescence detection combined complete or detection method, the immobilon-p includes nitrocellulose
Film, polyvinylidene fluoride film, nylon membrane, DEAE cellulose membranes, the one or both sides of the immobilon-p carry backing;In the present invention,
The polyvinylidene fluoride film abbreviation pvdf membrane;The DEAE cellulose membranes refer to diethyl amino ethyl group (DEAE) introducing cellulose
Manufactured paper-like film after molecule, it is a kind of weak base type anion-exchange material;The detector is chemiluminescence detector, institute
State the one or both sides that detector is located at the immobilon-p.
In above-mentioned paper chromatography chemiluminescence detection combined complete, the detection combination suit also includes the cleaning
Liquid, the cleaning fluid are the normal experiment cushioning liquid containing surfactant.Currently used surfactant has
TWEEN20, TritonX-100, TritonX-405 etc..
In above-mentioned paper chromatography chemical luminescence detection method, the cleaning fluid is used for the normal experiment containing surfactant
Cushioning liquid.
In above-mentioned paper chromatography chemiluminescence detection combined complete, the detection combination suit also includes the second thing to be checked
Specificity junction mixture, intermediate material A, intermediate material B, thing specificity junction mixture to be checked specificity junction mixture at least one
Kind.
Application of the described combined complete or detection method in immune detection product development.
In above-mentioned paper chromatography chemical luminescence detection method, the chemical luminous substrate of the HRPO often with luminol and
The different Shandong promise of base-N- ethyls of different luminol and its derivative species, such as different luminol, 4- amino and AHEI and ABEI, mesh
Preceding conventional product has the West Pico chemiluminescence detections substrate of PIERCE companies production, West Dura chemiluminescence detections
Substrate, West Femto chemiluminescence detection substrates.What the chemical luminous substrate of alkaline phosphatase was commonly used has (golden steel alkane) -1,2-
Dichloroethane and its derivative, AMPPD, CDP-STAR, Lumi-Phos 530.The chemical luminous substrate of xanthine oxidase has
Xanthine, myricetin, Quercetin.
In above-mentioned paper chromatography chemical luminescence detection method, non-enzyme-catalyzed chemical luminescence substrate, i.e., direct chemiluminescent substance,
It is the immunoassay method with the direct labelled antigen of chemiluminescence agent or antibody.The chemiluminescent substance for being usually used in mark has acridine
Ester type compound-acridinium ester (AE), are effective luminous markers, it is by starting luminescence reagent
(NaOH、H2O2)Act on and light, mainly there is acridinium ester and a word used for translation shallow lake amide-type, tris (bipyridine) ruthenium etc..
For the present invention due to taking above technical scheme, it has advantages below:
1st, the present invention uses carrying carrier of the particulate as thing to be checked and its intermediate reaction material, and chromatographic flow is simultaneously on immobilon-p
Reaction is completed, improves capture binding ability of the immobilon-p to thing to be checked and its intermediate reaction material.
2nd, the liquid phase that the present invention is driven using centrifugal device chromatographic flow on immobilon-p, can be effectively reduced to be special
Property capture chemiluminescent substance and immobilon-p non-specific binding, reduce immobilon-p ambient noise interference, improve inspection
Survey sensitivity.
3rd, existing flat board and magnetic microparticle separating chemiluminescence detection technique, using multi-step, too many levels drive control,
It is related to detection sample, detection phase and the transposition and movement of reaction carriers and needs to carry out under temperature control.The present invention adopts
Chemiluminescence detection is carried out with paper chromatography, room temperature is optimized for and the single mode of chromatographic flow is reacted, shorten detection time, letter
Operation and the design of corresponding instrument and cost of manufacture are changed.
4th, operating procedure of the present invention is simple, it is easy to accomplish automation mechanized operation.The inventive method has high sensitivity, Quan Ding
The characteristics of amount, automation, while have that detection is quick, uses the simple detection technique of equipment again;Not only easy to use, reduction original
The waste of material, while operating efficiency is also significantly improved, applied to detection and analysis, the numerous areas of separation.
Brief description of the drawings
Fig. 1 is the schematic diagram of the paper chromatography chemiluminescence detection combined complete of the embodiment of the present invention 1.
1 thing specificity junction mixture to be checked;2 particulates;3 immobilon-ps;4 chemiluminescent reactants;5 centrifugal devices;6 luminous inspections
Survey device;7 second thing specificity junction mixtures or intermediate material B to be checked.
Embodiment
The present invention is further described below in conjunction with the accompanying drawings, but the invention is not limited in following examples.
The preparation of embodiment 1, paper chromatography chemiluminescence detection combined complete of the present invention:
As shown in figure 1, paper chromatography chemiluminescence detection combined complete of the present invention includes, thing specificity junction mixture 1 to be checked, particulate 2,
Immobilon-p 3, chemiluminescence enzyme or chemiluminescent substance 4, centrifugal device 5, luminescence detector 6, chemiluminescence enzyme reaction substrate or
Luminescence reagent 7 is started, while also includes the second thing specificity junction mixture or intermediate material B 8 to be checked, mark adsorbed film pad 9, inhale
Water film bearing 10, support egative film 11.Thing specificity junction mixture 1 and chemiluminescence enzyme or chemiluminescent substance 4 to be checked and the knot of particulate 2
Close, and be printed on mark adsorbed film pad 8.The second thing specificity junction mixture or intermediate material B to be checked is printed with immobilon-p 3 to catch
Obtain detection line 8.Binding mark adsorbed film pad 9, immobilon-p 3 and absorbing membrane pad 10 successively on support egative film 11, detection examination is made
Paper slip.During detection, test strip is placed on centrifugal device 5, loads on mark adsorbed film pad 8 and is treated containing thing to be checked
Sample sheet, be now marked with the particulate 2 of thing specificity junction mixture 1 and chemiluminescence enzyme or chemiluminescent substance 4 to be checked with it is to be checked
Thing combines, and forms thing compound to be checked, and chromatography flows through immobilon-p 3, and the thing compound to be checked formed is coated on immobilon-p 3
Acquisition Detection line 7 captured, carry out chromatography cleaning, then by chemiluminescence enzyme reaction substrate or start luminescence reagent 7 it is anti-
Should, and then luminous, the chemiluminescence captured indirectly using Acquisition Detection line 8 of the detection of luminescence detector 6 on immobilon-p 3
The luminous quantity of enzyme or chemiluminescent substance 4, and then obtain the content of thing to be checked, wherein sample introduction, capture and the process of cleaning from
Completed on center device 5 by centrichromatography.
The detection method and its effect of following description of test present invention, but be not limitation of the invention.In following experiments
Used experimental method is conventional method unless otherwise specified.Material used, reagent etc. in following experiments, such as without spy
Different explanation, is commercially obtained.
Experiment one, paper chromatography chemiluminescence detection of the present invention experiment(One)
Using colloidal gold particles as liquid phase reactor delivery vehicle, tested using methods described A.
First, experiment material
Anti-human myoglobins polyclonal antibody(Genagates companies of the U.S.), anti-human myoglobins monoclonal antibody(The U.S.
Genagates companies), HRPO(HRP, SIGMA product), spectrophotometer(The limited public affairs of Shanghai mountain valley with clumps of trees and bamboo China tech equipment
Department, 752 ultraviolet-uisible spectrophotometers), human muscle hemoglobin(Sigma-Aldrich products), BioFlow die instrument(The U.S.
IMAGENE companies), Index cutting machines(A-point companies of the U.S.), DBF-900 sealing machines(Wenzhou south of the River packing factory),
ACBO dehumidifiers(Jiangsu wuxi Ao Bo dehumidifiers company), desk centrifuge(Eppendoff companies of the U.S.), bovine serum albumin
In vain(Abbreviation BSA, SIGMA product), nitrocellulose diaphragm(AE 99, provided by Genagates companies of the U.S.), multi-polyester fibre
Plain film (Reemay 2033, U.S.'s Alstrom Products) is tieed up, absorb water paper membrane pad(Grade 470, the production of S&S companies of the U.S.
Product), gold chloride(SIGMA products), chemiluminescence detector(Promega, Glomax Multi JR Detection
System), West Pico luminescence reagents(Thermo scientific).
It is as follows that above-mentioned material corresponds to Patent Application Request content, and the anti-human myoglobins polyclonal antibody of this experiment is second to treat
Thing specificity junction mixture is examined, anti-human myoglobins monoclonal antibody is thing specificity junction mixture to be checked, and HRPO is change
Chemiluminescence enzyme, the human muscle hemoglobin for learning luminescence-producing reaction thing are thing to be checked, and desk centrifuge is centrifugal device, nitrocellulose filter
Piece is immobilon-p, and gold chloride is the material for preparing particulate, and chemiluminescence detector is luminescence detector, and West Pico chemistry is sent out
Light detection substrate is the chemiluminescence enzyme reaction substrate of chemiluminescent reactant.
2nd, experimental method
The preparation of human muscle hemoglobin solution:The human muscle hemoglobin solution of concentration known is taken, uses sample dilution buffer(1%BSA,
100mM glycine, 50mM PBS, 150mM NaCl, pH7.4)Dilution configuration 0.1,1.0,10,100,500,1000ng/ml
Serial human muscle hemoglobin solution.
Colloidal gold particles mark:10ml pure water is taken, heating stirring, it is molten that the gold chlorides of 500 μ l 10% are added when boiling water
Liquid, heating are boiled 5 minutes, add the citric acid three sodium solutions of 500 μ l 12%, are kept this solution stirring boiling 10 minutes, are dropped naturally
Warm to room temperature, produce particle diameter 50nm colloidal gold particles solution.Colloidal gold solution volume 10ml is taken, pH is adjusted extremely with 10% potassium carbonate
8.3, the anti-human μ g of myoglobins monoclonal antibody 100, the μ g of HRPO 100 are rapidly added, to each 10 μ g/ml final concentrations,
Beaker mixing is rocked, room temperature is placed 30 minutes, is rapidly added 10% bovine serum albumin solution 100ul, makes final concentration of 1%, together
When shake beaker, room temperature is placed 30 minutes, and 12000rpm is centrifuged 20 minutes, carefully suctions out supernatant;Add 5ml 50mM phosphorus
Hydrochlorate (PBS) buffer solution, pH7.4, precipitation is suspended, 12000rpm is centrifuged 20 minutes, suctions out supernatant, precipitation is dissolved in
1.0ml contains in 1% bovine serum albumin(BSA) and the phosphate buffer of 3% sucrose, and 4 DEG C are kept in dark place.
Colloidal gold particles mark absorption film preparation:Preparation contains 0.5%PVA(That is polyvinyl alcohol), 50mM PBS liquid, 0.5%
BSA, 0.88% NaCl, pH 7.4 multi-polyester cellulose membrane pretreatment fluid, pending multi-polyester cellulose membrane is put in pre- place
Manage in liquid, soaking at room temperature 1 hour, take the film out, put and seal after 37 DEG C of dryings standby, can also be used directly as dispersion membrane.Take
Colloidal gold particles labelled antibody solution, with colloid buffer solution(1%BSA, 3% sucrose, 50mM PBS, pH7.4)It is diluted to OD530
For 30, start die instrument, load antibody, open pressurized nitrogen, take multi-polyester cellulose membrane, start die, set die condition
For:The airbrush translational speed 30mm/ seconds, the μ l/cm of liquid fltting speed 5.0, the film after printing is put into drying box, 37 DEG C dry
Dry 6 hours, it is subsequently placed in the hermetic bag containing drier and preserves use.
It is prepared by polyclonal antibody die:Anti-human myoglobins Anti-TNF-α liquid solution is taken, with 50mM phosphate buffers
(pH 7.4) is diluted to 1mg/ml concentration.Start die instrument, load antibody, take the PVC pieces for posting nitrocellulose filter(That is polychlorostyrene
Piece of vinyl), start die, set die condition as:Airbrush translational speed 30mm/ seconds, the μ l/cm of liquid fltting speed 1.5.Will print
The film made is put into 37 DEG C of drying boxes, dries 6 hours, then film is placed in the drying receptacle containing drier and preserves use.
Semi-finished product assemble method:Starting dehumidifier makes the humidity in operating room be reduced to less than 25%, is printed in polyclonal antibody
Water suction paper membrane pad and colloidal gold particles mark adsorbed film are pasted in film both ends respectively, then with Pressure sensitive adhesive tape sealing label surface.Put stickup
Good detection lug is on cutting machine, being cut into 3.5mm test strips.Test strips are put into the aluminium amber hermetic bag of drier, sealed
Sealed on mouth machine, labelling.
Experimental group:The test strips of above-mentioned preparation are taken, with the side of colloidal gold particles mark adsorbed film upward, are placed in centrifuge
In rotor, the human muscle hemoglobin solution 80ul for the various concentrations that preparation is added dropwise on adsorbed film is marked to colloidal gold particles, stands 2 points
Clock, with 1000 revs/min centrifuge 1 minute, then to colloidal gold particles mark adsorbed film on be added dropwise pH7.4 0.05% Tween-20,
50mM PBSs 80ul, 2000 revs/min of centrifugations are cleaned for 30 seconds, and cleaning twice, takes out test strips, cuts polyclonal antibody print
Film detection line, is positioned in cuvette, adds West Pico chemiluminescence detection substrates, 5 minutes is stood, in chemiluminescence
6 seconds luminous quantities are read on detector, experiment in triplicate, results averaged, then draws concentration-luminosity curve, and calculate
Coefficient correlation.
Control group:The test strips of above-mentioned preparation are taken, are placed in desktop, is marked to colloidal gold particles and is added dropwise what is prepared on adsorbed film
The human muscle hemoglobin solution 80ul of various concentrations, stand, treat the red colloid gold particulate mark on colloidal gold particles mark adsorbed film
Remember thing all chromatography flow into nitrocellulose filter, then to colloidal gold particles mark adsorbed film on be added dropwise pH7.4 0.05% tween-
20th, 50mM PBSs 80ul, stand, liquid all flows into nitrocellulose filter, and cleaning twice, is removed test strips, cut
Polyclonal antibody die detection line, is positioned in cuvette, adds West Pico chemiluminescence detection substrates, stands 5 points
Clock, reads 6 seconds luminous quantities on chemiluminescence detector, and experiment in triplicate, results averaged, then draws concentration-hair
Light curve, and calculate coefficient correlation.
3rd, experimental result
The present invention is tested using colloidal gold particles as liquid phase reactor delivery vehicle using methods described A, as a result, the present invention is real
Test group test strips single detection process time average out to 4.6 minutes, control test group(Do not do centrifugal treating)Test strips single is examined
Survey processing time average out to 47 minutes;Experimental group detection data of the present invention are in the dependency relation of good concentration-luminous value, related
Coefficient r is 0.995, and control group detects data in below 100ng/ml, the substantially correlation without concentration-luminous value, mainly by
It can not be effectively cleaned in non-specific binding of the chemiluminescence enzyme on immobilon-p, cause background too high relevant, phase relation
Number r is 0.776, P < 0.05, and result of the present invention is significantly better than the testing result for not doing centrifugal treating, illustrates that the technology of the present invention carries
The high linear and accuracy of prior art detection.Experimental result is as shown in table 1.
The paper chromatography chemical luminescence detection method A experimental results of the present invention of table 1(Unit:Luminous value)
Experiment two, paper chromatography chemiluminescence detection of the present invention experiment(Two)
Using colloidal gold particles as liquid phase reactor delivery vehicle, tested using methods described B.
First, experiment material
Alkaline phosphatase(ALP, Roche Holding Ag's product), sheep anti-mouse igg polyclonal antibody(Genagates companies of the U.S.), APLS
Luminescence reagent(Zhengzhou English promise biology), it is other with experiment one.
Above-mentioned material corresponds to that Patent Application Request content is as follows, and this experiment alkaline phosphatase is the change of chemiluminescent reactant
Learn Luminescence Enzyme, the specificity junction mixture that sheep anti-mouse igg polyclonal antibody is thing specificity junction mixture to be checked, APLS luminescence reagents are
The chemiluminescence enzyme reaction substrate of chemiluminescent reactant, it is other with experiment one.
2nd, experimental method
The preparation of human muscle hemoglobin solution:With experiment one.
The alkali phosphatase enzyme mark of sheep anti-mouse igg polyclonal antibody:Using improvement Over-voltage protection, l mg alkalescence phosphorus is taken
Sour enzyme is dissolved in the M pH 8.0 of 200uL 0.3 NaHCO3In buffer solution, add the M of l ml 0.06 sodium periodate, at room temperature lucifuge
Gently stir 0.5 hour, add 1 ml 0.16M ethylene glycol, gently stir at room temperature 1 hour, oxidation is terminated, in 0.01 M pH 9.5 carbon
4 DEG C of dialysed overnights in phthalate buffer, the carbonate buffer solution l ml containing 0.5 mg antibody being added, room temperature lucifuge is gently stirred 3 hours,
Add 5 mg NaHB4, 4 DEG C overnight, in 0.01 M, the PBSs of pH 7.2 4 DEG C dialyse 24 hours, 4 DEG C of 4000rpm from
The heart 30 divides, and removes precipitation, adds isometric glycerine, -20 DEG C of preservations.
Colloidal gold particles mark:Colloidal gold solution volume 10ml is taken, pH to 8.3 is adjusted with 10% potassium carbonate, is rapidly added anti-human
The μ g of myoglobins monoclonal antibody 100, to 10 μ g/ml final concentrations, rock beaker mixing.Other same experiments one.
Colloidal gold particles mark absorption film preparation:With experiment one.
It is prepared by polyclonal antibody die:With experiment one.
Semi-finished product assemble method:With experiment one.
Experimental group:The test strips of above-mentioned preparation are taken, with the side of colloidal gold particles mark adsorbed film upward, are placed in centrifuge
In rotor, the human muscle hemoglobin solution 80ul for the various concentrations that preparation is added dropwise on adsorbed film is marked to colloidal gold particles, stands 2 points
Clock, centrifuged 1 minute with 1000 revs/min, mark dropwise addition alkali phosphatase enzyme mark sheep anti-mouse igg on adsorbed film more to colloidal gold particles
Clonal antibody solution 80ul, 2 minutes are stood, centrifuged 1 minute with 1000 revs/min, then marked to colloidal gold particles and dripped on adsorbed film
Add pH7.4 0.05% Tween-20,50mM PBSs 80ul, 2000 revs/min of centrifugations are cleaned for 30 seconds, and cleaning twice, is taken out
Test strips, polyclonal antibody die detection line is cut, is positioned in cuvette, add APLS chemiluminescence detection substrates, it is quiet
Put 1 minute, 6 seconds luminous quantities are read on chemiluminescence detector, experiment in triplicate, results averaged, is then drawn dense
Degree-luminosity curve, and calculate coefficient correlation.
Control group:The test strips of above-mentioned preparation are taken, are placed in desktop, is marked to colloidal gold particles and is added dropwise what is prepared on adsorbed film
The human muscle hemoglobin solution 80ul of various concentrations, stand, treat the red colloid gold particulate mark on colloidal gold particles mark adsorbed film
Remember that all chromatography flows into nitrocellulose filter to thing, marks to colloidal gold particles and alkali phosphatase enzyme mark sheep anti mouse is added dropwise on adsorbed film
IgG Anti-TNF-α liquid solution 80ul, stand, liquid all flows into nitrocellulose filter, then marks adsorbed film to colloidal gold particles
Upper dropwise addition pH7.4 0.05% Tween-20,50mM PBS 80ul, stand, liquid all flows into nitrocellulose filter, clearly
Wash twice, remove test strips, cut polyclonal antibody die detection line, be positioned in cuvette, add APLS chemiluminescences
Detection substrate, 1 minute is stood, 6 seconds luminous quantities is read on chemiluminescence detector, tested in triplicate, results averaged,
Then concentration-luminosity curve is drawn, and calculates coefficient correlation.
3rd, experimental result
This experiment is tested using colloidal gold particles as liquid phase reactor delivery vehicle using methods described B, as a result, the present invention is real
Test group test strips single detection process time average out to 7.8 minutes, control test group(Do not do centrifugal treating)Test strips single is examined
Survey processing time average out to 62 minutes;Experimental group detection data of the present invention are in the dependency relation of good concentration-luminous value, related
Coefficient r is 0.994, and control group detects data in below 100ng/ml, the substantially correlation without concentration-luminous value, mainly by
It can not be effectively cleaned in non-specific binding of the chemiluminescence enzyme on immobilon-p, cause background too high relevant, phase relation
Number r is 0.807, P < 0.05, and result of the present invention is significantly better than the testing result for not doing centrifugal treating, illustrates that the technology of the present invention carries
The high linear and accuracy of prior art detection.Experimental result is as shown in table 2.
The paper chromatography chemical luminescence detection method B experimental results of the present invention of table 2(Unit:Luminous value)
Experiment three, paper chromatography chemiluminescence detection of the present invention experiment(Three)
Using colloidal gold particles as liquid phase reactor delivery vehicle, tested using methods described C.
First, experiment material
NHS activated biotins(SIGMA,), Avidin(SIGMA), it is other with experiment one.
Above-mentioned material corresponds to that Patent Application Request content is as follows, and this bioorganism element is intermediate material A, Avidin is middle
Substance B, it is other with experiment one.
2nd, experimental method
The preparation of human muscle hemoglobin solution:With experiment one.
Anti-human myoglobins polyclonal antibody biotin labeling:Anti-human myoglobins polyclonal antibody is taken in 0.1M pH9.5
Dialysed overnight in sodium carbonate buffer, adjust final concentration of 2mg/ml.NHS activated biotins 20mg is taken to be dissolved in 1ml dimethyl methyls
Acid amides, 50ul is taken, be added in above-mentioned solution, reacted at room temperature 4 hours.Reaction solution is dialyzed overnight in PBS, -20 DEG C
Preserve.
Colloidal gold particles mark:With experiment one.
Colloidal gold particles mark absorption film preparation:Colloidal gold particles labelled antibody solution is taken, with colloid buffer solution(1%BSA,
3% sucrose, 50mM PBS, pH7.4)It is 30 to be diluted to OD530, adds the anti-human myoglobins polyclonal antibody 10 of biotin labeling
μ g/ml, mix.Other same experiments one.
It is prepared by Avidin die:Avidin solution is taken, it is dense to be diluted to 1mg/ml with 50mM phosphate buffers (pH 7.4)
Degree.Start die instrument, load avidin solution, it is other with experiment one.
Semi-finished product assemble method:Starting dehumidifier makes the humidity in operating room be reduced to less than 25%, in Avidin die two
Water suction paper membrane pad and colloidal gold particles mark adsorbed film are pasted in end respectively, other with experiment one.
Experimental group:The test strips of above-mentioned preparation are taken, with the side of colloidal gold particles mark adsorbed film upward, are placed in centrifuge
In rotor, the human muscle hemoglobin solution 80ul for the various concentrations that preparation is added dropwise on adsorbed film is marked to colloidal gold particles, stands 2 points
Clock, with 1000 revs/min centrifuge 1 minute, then to colloidal gold particles mark adsorbed film on be added dropwise pH7.4 0.05% Tween-20,
50mM PBSs 80ul, 2000 revs/min of centrifugations are cleaned for 30 seconds, and cleaning twice, takes out test strips, cuts the inspection of Avidin die
Survey line, it is positioned in cuvette, adds West Pico chemiluminescence detection substrates, 5 minutes is stood, in chemiluminescence detection
6 seconds luminous quantities are read on instrument, experiment in triplicate, results averaged, then draws concentration-luminosity curve, and calculate correlation
Coefficient.
Control group:The test strips of above-mentioned preparation are taken, are placed in desktop, is marked to colloidal gold particles and is added dropwise what is prepared on adsorbed film
The human muscle hemoglobin solution 80ul of various concentrations, stand, treat the red colloid gold particulate mark on colloidal gold particles mark adsorbed film
Remember thing all chromatography flow into nitrocellulose filter, then to colloidal gold particles mark adsorbed film on be added dropwise pH7.4 0.05% tween-
20th, 50mM PBSs 80ul, stand, liquid all flows into nitrocellulose filter, and cleaning twice, is removed test strips, cut
Avidin die detection line, is positioned in cuvette, adds West Pico chemiluminescence detection substrates, stands 5 minutes,
6 seconds luminous quantities are read on chemiluminescence detector, experiment in triplicate, results averaged, then draws concentration-luminous song
Line, and calculate coefficient correlation.
3rd, experimental result
This experiment is tested using colloidal gold particles as liquid phase reactor delivery vehicle using methods described C, as a result, the present invention is real
Test group test strips single detection process time average out to 4.6 minutes, control test group(Do not do centrifugal treating)Test strips single is examined
Survey processing time average out to 42 minutes;Experimental group detection data of the present invention are in the dependency relation of good concentration-luminous value,
500ng/ml has just reached reaction platform, correlation coefficient r 0.987, and control group detects data in below 100ng/ml, does not have substantially
There is the correlation of concentration-luminous value, can not be by effectively mainly due to non-specific binding of the chemiluminescence enzyme on immobilon-p
Cleaning, causes background too high relevant, correlation coefficient r 0.866, P < 0.05, result of the present invention, which is significantly better than, does not do centrifugal treating
Testing result, illustrate the technology of the present invention improve prior art detection linear and accuracy.Meanwhile add intermediate material production
Signal amplification has been given birth to, has improved the response intensity of each concentration.Experimental result is as shown in table 3.
The paper chromatography chemical luminescence detection method C experimental results of the present invention of table 3(Unit:Luminous value)
Experiment four, paper chromatography chemiluminescence detection of the present invention experiment(Four)
Using colloidal gold particles as liquid phase reactor delivery vehicle, tested using methods described D.
First, experiment material
NHS activated biotins(SIGMA,), Avidin(SIGMA), alkaline phosphatase(ALP, Roche Holding Ag's product), sheep anti mouse
IgG polyclonal antibodies(Genagates companies of the U.S.), APLS luminescence reagents(Zhengzhou English promise biology), it is other with experiment one.
Above-mentioned material corresponds to that Patent Application Request content is as follows, and this experiment alkaline phosphatase is the change of chemiluminescent reactant
Learn Luminescence Enzyme, the specificity junction mixture that sheep anti-mouse igg polyclonal antibody is thing specificity junction mixture to be checked, biotin is intermediate
Matter A, Avidin are the chemiluminescence enzyme reaction substrate that intermediate material B, APLS luminescence reagent are chemiluminescent reactant, Qi Tatong
Experiment one.
2nd, experimental method
The preparation of human muscle hemoglobin solution:With experiment one.
Sheep anti-mouse igg polyclonal antibody alkali phosphatase enzyme mark:With experiment two.
Anti-human myoglobins polyclonal antibody biotin labeling:With experiment three.
Colloidal gold particles mark:With experiment two.
Colloidal gold particles mark absorption film preparation:With experiment three.
It is prepared by Avidin die:With experiment three.
Semi-finished product assemble method:With experiment three.
Experimental group:The test strips of above-mentioned preparation are taken, with the side of colloidal gold particles mark adsorbed film upward, are placed in centrifuge
In rotor, the human muscle hemoglobin solution 80ul for the various concentrations that preparation is added dropwise on adsorbed film is marked to colloidal gold particles, stands 2 points
Clock, centrifuged 1 minute with 1000 revs/min, mark dropwise addition alkali phosphatase enzyme mark sheep anti-mouse igg on adsorbed film more to colloidal gold particles
Clonal antibody solution 80ul, 2 minutes are stood, centrifuged 1 minute with 1000 revs/min, then marked to colloidal gold particles and dripped on adsorbed film
Add pH7.4 0.05% Tween-20,50mM PBSs 80ul, 2000 revs/min of centrifugations are cleaned for 30 seconds, and cleaning twice, is taken out
Test strips, Avidin die detection line is cut, is positioned in cuvette, add APLS chemiluminescence detection substrates, stand 1 point
Clock, reads 6 seconds luminous quantities on chemiluminescence detector, and experiment in triplicate, results averaged, then draws concentration-hair
Light curve, and calculate coefficient correlation.
Control group:The test strips of above-mentioned preparation are taken, are placed in desktop, is marked to colloidal gold particles and is added dropwise what is prepared on adsorbed film
The human muscle hemoglobin solution 80ul of various concentrations, stand, treat the red colloid gold particulate mark on colloidal gold particles mark adsorbed film
Remember that all chromatography flows into nitrocellulose filter to thing, marks to colloidal gold particles and alkali phosphatase enzyme mark sheep anti mouse is added dropwise on adsorbed film
IgG Anti-TNF-α liquid solution 80ul, stand, liquid all flows into nitrocellulose filter, then marks adsorbed film to colloidal gold particles
Upper dropwise addition pH7.4 0.05% Tween-20,50mM PBS 80ul, stand, liquid all flows into nitrocellulose filter, clearly
Wash twice, remove test strips, cut Avidin die detection line, be positioned in cuvette, add APLS chemiluminescence detections
Substrate, 1 minute is stood, 6 seconds luminous quantities are read on chemiluminescence detector, tested in triplicate, results averaged, then
Concentration-luminosity curve is drawn, and calculates coefficient correlation.
3rd, experimental result
This experiment is tested using colloidal gold particles as liquid phase reactor delivery vehicle using methods described D, as a result, the present invention is real
Test group test strips single detection process time average out to 7.9 minutes, control test group(Do not do centrifugal treating)Test strips single is examined
Survey processing time average out to 58 minutes;Experimental group detection data of the present invention are in the dependency relation of good concentration-luminous value, related
Coefficient r is 0.987, and control group detects data in below 100ng/ml, the substantially correlation without concentration-luminous value, mainly by
It can not be effectively cleaned in non-specific binding of the chemiluminescence enzyme on immobilon-p, cause background too high relevant, phase relation
Number r is 0.841, P < 0.05, and result of the present invention is significantly better than the testing result for not doing centrifugal treating, illustrates that the technology of the present invention carries
The high linear and accuracy of prior art detection.Meanwhile add intermediate material and generate signal amplification, improve each dense
The response intensity of degree.Experimental result is as shown in table 4.
The paper chromatography chemical luminescence detection method D experimental results of the present invention of table 4(Unit:Luminous value)
Experiment five, paper chromatography chemiluminescence detection of the present invention experiment(Five)
Using fluorescent microsphere as liquid phase reactor delivery vehicle, tested using methods described E.
First, experiment material
Fluorescent microsphere(The biology of Shanghai outstanding person one), trehalose(SIGMA), nitrocellulose filter(Millipore companies), EDC
(PIERCE companies), NHS(PIERCE companies), NHS activation acridinium esters(Acridinium NHS ester, Shanghai are prosperous happy raw
Thing), start luminescence reagent(26.8 mM H2O2The ul of solution 50 and containing the ul of 0.2 M NaOH solution 300, used time mixing), its
It is the same as experiment one.
It is as follows that above-mentioned material corresponds to Patent Application Request content, and this experimental fluorescence microballoon is particulate, and NHS activation acridinium esters are
The chemiluminescent substance of chemiluminescent reactant, the starting luminescence reagent that luminescence reagent is chemiluminescent reactant is started, it is other
With experiment one.
2nd, experimental method
The preparation of human muscle hemoglobin solution:With experiment one.
Anti-human myoglobins monoclonal antibody acridinium ester label:The anti-human myoglobins monoclonal antibodies of 5mg are taken, add the concentration to be
0.2M sodium bicarbonate aqueous solution(pH8.3)2ml dissolves.Resisted with the mg/ml NHS of 8ul concentration 20 acridinium esters activated with 1 mg
The ratio hybrid reaction of human muscle hemoglobin polyclonal antibody, 4 DEG C, concussion reaction 4 hours.Stayed overnight again with pH7.4 PBS
Dialysis, removes free acridinium ester, 4 DEG C save backup.
Fluorescent microsphere marks:0.5ml microballoons are taken, using pH7.2 0.1M phosphate buffers eccentric cleaning 4 times,
13000rpm is centrifuged, and is redissolved with pH7.2 0.1M phosphate buffers to 1ml, is added the 200 anti-human flesh red eggs of μ g acridinium ester labels
White monoclonal antibody, mix, add 250ul 40mg/ml EDC solution, add 250ul 40mg/ml NHS solution, mix
It is even, react at room temperature 60 minutes, add 20mg bovine serum albumin(BSA), mix, react at room temperature 60 minutes.Supernatant is abandoned in centrifugation suction, is made
After 0.05M Tris pH7.6 eccentric cleanings 4 times, with 0.5% trehalose, 1%BSA, 0.05M Tris pH7.6 redissolve to
10ml, 4 DEG C be kept in dark place it is stand-by.
Fluorescent microsphere mark absorption film preparation:Fluorescent microsphere labelled antibody solution is taken, with pH7.2 0.1M phosphoric acid buffers
Liquid dilutes 2 times, other same experiments one.
It is prepared by polyclonal antibody die:With experiment one.
Semi-finished product assemble method:With experiment one.
Experimental group:The test strips of above-mentioned preparation are taken, with the side of fluorescent microsphere mark adsorbed film upward, are placed in centrifugal basket
In son, the human muscle hemoglobin solution 80ul for the various concentrations that preparation is added dropwise on adsorbed film is marked to fluorescent microsphere, stands 2 minutes,
Centrifuged 1 minute with 1000 revs/min, then 0.05% Tween-20,50mM PBS to dropwise addition pH7.4 on fluorescent microsphere mark adsorbed film
Buffer solution 80ul, 2000 revs/min of centrifugations are cleaned for 30 seconds, and cleaning twice, takes out test strips, cuts the detection of polyclonal antibody die
Line, it is positioned in cuvette, is placed on chemiluminescence detector, adds and start luminescence reagent, time delay is 0.30 second,
The luminous quantity time of integration is 10 seconds, and experiment in triplicate, results averaged, then draws concentration-luminosity curve, and calculate phase
Relation number.
Control group:The test strips of above-mentioned preparation are taken, are placed in desktop, marks to be added dropwise on adsorbed film to fluorescent microsphere and prepares not
With the human muscle hemoglobin solution 80ul of concentration, stand, treat that the liquid on fluorescent microsphere mark adsorbed film all chromatographs and flow into nitric acid
Cellulose membrane, then 0.05% Tween-20,50mM PBS 80ul to dropwise addition pH7.4 on fluorescent microsphere mark adsorbed film,
Stand, liquid all flows into nitrocellulose filter, and cleaning twice, removes test strips, cuts polyclonal antibody die detection line, put
It is placed in cuvette, is placed on chemiluminescence detector, add and start luminescence reagent, time delay is 0.30 second, luminous quantity
The time of integration is 10 seconds, and experiment in triplicate, results averaged, then draws concentration-luminosity curve, and calculate phase relation
Number.
3rd, experimental result
This experiment is tested using fluorescent microsphere as liquid phase reactor delivery vehicle using methods described E, as a result, present invention experiment
Group test strips single detection process time average out to 4.7 minutes, control test group(Do not do centrifugal treating)Test strips single detects
Processing time average out to 48 minutes;Experimental group detection data of the present invention are in the dependency relation of good concentration-luminous value, phase relation
Number r are 0.981, and control group detects data in below 100ng/ml, the substantially correlation without concentration-luminous value, mainly due to
Non-specific binding of the chemiluminescent substance on immobilon-p can not be effectively cleaned, and cause background too high relevant, phase relation
Number r is 0.908, P < 0.05, and result of the present invention is significantly better than the testing result for not doing centrifugal treating, illustrates that the technology of the present invention carries
The high linear and accuracy of prior art detection.Experimental result is as shown in table 5.
The paper chromatography chemical luminescence detection method E experimental results of the present invention of table 5(Unit:Luminous value)
Experiment six, paper chromatography chemiluminescence detection of the present invention experiment(Six)
Using fluorescent microsphere as liquid phase reactor delivery vehicle, tested using methods described F.
First, experiment material
Sheep anti-mouse igg polyclonal antibody(Genagates companies of the U.S.), it is other with experiment five.
It is as follows that above-mentioned material corresponds to Patent Application Request content, and this experiment sheep anti-mouse igg polyclonal antibody is that thing to be checked is special
The specificity junction mixture of specific binding agent, it is other with experiment five.
2nd, experimental method
The preparation of human muscle hemoglobin solution:With experiment one.
Sheep anti-mouse igg polyclonal antibody acridinium ester label:The anti-human myoglobins polyclonal antibodies of 5mg are taken, add the concentration to be
0.2M sodium bicarbonate aqueous solution(pH8.3)2 ml dissolve.The acridinium ester and 1 mg activated with the mg/ml NHS of 8ul concentration 20
The ratio hybrid reaction of anti-human myoglobins polyclonal antibody, 4 DEG C, concussion reaction 4 hours.PH7.4 PBS salting liquid mistakes are used again
Night dialyses, and removes free acridinium ester, 4 DEG C save backup.
Fluorescent microsphere marks:0.5ml microballoons are taken, using pH7.2 0.1M phosphate buffers eccentric cleaning 4 times,
13000rpm is centrifuged, and is redissolved with pH7.2 0.1M phosphate buffers to 1ml, is added the anti-human myoglobins monoclonals of 200 μ g and is resisted
Body, mix, it is other with experiment five.
Fluorescent microsphere mark absorption film preparation:With experiment five.
It is prepared by polyclonal antibody die:With experiment five.
Semi-finished product assemble method:With experiment five.
Experimental group:The test strips of above-mentioned preparation are taken, with the side of fluorescent microsphere mark adsorbed film upward, are placed in centrifugal basket
In son, the human muscle hemoglobin solution 80ul for the various concentrations that preparation is added dropwise on adsorbed film is marked to fluorescent microsphere, stands 2 minutes,
Centrifuged 1 minute with 1000 revs/min, marked to fluorescent microsphere and acridinium ester label sheep anti-mouse igg polyclonal antibody is added dropwise on adsorbed film
Solution 80ul, 2 minutes are stood, centrifuged 1 minute with 1000 revs/min, then marked to fluorescent microsphere and be added dropwise pH7.4's on adsorbed film
0.05% Tween-20,50mM PBSs 80ul, 2000 revs/min of centrifugations are cleaned for 30 seconds, and cleaning twice, is taken out test strips, cut
Polyclonal antibody die detection line is taken, is positioned in cuvette, is placed on chemiluminescence detector, adds and starts luminous examination
Agent, time delay are 0.30 second, and the luminous quantity time of integration is 10 seconds, and experiment in triplicate, results averaged, is then drawn
Concentration-luminosity curve, and calculate coefficient correlation.
Control group:The test strips of above-mentioned preparation are taken, are placed in desktop, marks to be added dropwise on adsorbed film to fluorescent microsphere and prepares not
With the human muscle hemoglobin solution 80ul of concentration, stand, treat that the liquid on fluorescent microsphere mark adsorbed film all chromatographs and flow into nitric acid
Cellulose membrane, dropwise addition acridinium ester label sheep anti-mouse igg Anti-TNF-α liquid solution 80ul on adsorbed film is marked to fluorescent microsphere, it is quiet
Put, liquid all flow into nitrocellulose filters, then to fluorescent microsphere mark adsorbed film on be added dropwise pH7.4 0.05% polysorbas20,
50mM PBS 80ul, stand, liquid all flows into nitrocellulose filter, and cleaning twice, removes test strips, cuts more grams
Grand antibody die detection line, is positioned in cuvette, is placed on chemiluminescence detector, adds and starts luminescence reagent, delay
Time is 0.30 second, and the luminous quantity time of integration is 10 seconds, and experiment in triplicate, results averaged, then draws concentration-hair
Light curve, and calculate coefficient correlation.
3rd, experimental result
This experiment is tested using colloidal gold particles as liquid phase reactor delivery vehicle using methods described F, as a result, the present invention is real
Test group test strips single detection process time average out to 7.8 minutes, control test group(Do not do centrifugal treating)Test strips single is examined
Survey processing time average out to 59 minutes;Experimental group detection data of the present invention are in the dependency relation of good concentration-luminous value, related
Coefficient r is 0.990, and control group detects data in below 100ng/ml, the substantially correlation without concentration-luminous value, mainly by
It can not be effectively cleaned in non-specific binding of the chemiluminescence enzyme on immobilon-p, cause background too high relevant, phase relation
Number r is 0.912, P < 0.05, and result of the present invention is significantly better than the testing result for not doing centrifugal treating, illustrates that the technology of the present invention carries
The high linear and accuracy of prior art detection.Experimental result is as shown in table 6.
The paper chromatography chemical luminescence detection method F experimental results of the present invention of table 6(Unit:Luminous value)
Experiment seven, influence of the centrifugal speed of the present invention to testing result
First, experiment material
With experiment one.
2nd, experimental method
Control group is not set, experimental group human muscle hemoglobin solution sample introduction uses 500,1000,2000,3000,4000,5000 revs/min
Centrifugation, 2000 revs/min of centrifugations of cleaning are other with experiment one.
3rd, experimental result
This experiment is tested using colloidal gold particles as liquid phase reactor delivery vehicle using methods described A, observes different centrifugation speed
Spend the influence to testing result.Experiment have detected the human muscle hemoglobin sample of various concentrations, and experimental result is as shown in table 7.By table 7
Understand, detection accuracy is relevant with centrifugal speed, and 500,1000,2000 revs/min of centrifugal speed obtains satisfactory detection
As a result.3000th, the testing result that 4000,5000 revs/min of centrifugal speed obtains, luminous value significantly decrease, influence to detect
Sensitivity and accuracy.Illustrate that the optimal centrifugal speed of present invention progress myoglobins detection should be below 2000 revs/min.
Influence of the centrifugal speed of table 7 to testing result(Unit:Luminous value)
Experiment eight, influence of the diameter of particle of the present invention to testing result
First, experiment material
Polystyrene microsphere(Particle diameter 45,201,376,600,1000nm, carboxylated, upper great waves space are international), it is other with experiment one.
Above-mentioned material corresponds to that Patent Application Request content is as follows, and this experiment polystyrene microsphere is particulate, other with experiment
One.
2nd, experimental method
The preparation of human muscle hemoglobin solution:With experiment one.
Polystyrene microsphere marks:Take 2ml acetate buffers, 0.01M, pH5.0,2mg antibody, the 5% of 0.2ml
W/v microballoons and 20mg EDC, mix, placed 2 hours on impeller oscillator at room temperature, 3000g is centrifuged 15 minutes, is abandoned
Supernatant, 4ml 50mM PBS, pH7.4 buffer solution is added to be suspended, repeated washing once, adds 2ml 50mM PBSs, 4 DEG C of guarantors
Deposit standby.
Polystyrene microsphere mark absorption film preparation:Polystyrene microsphere labelled antibody solution is taken, with 50mM PBS,
PH7.4 buffer solutions are diluted to 1% w/v microballoons, start die instrument, load antibody, open pressurized nitrogen, take poly ester fiber element
Film, start die, set die condition as:Airbrush translational speed 30mm/ seconds, the μ l/cm of liquid fltting speed 5.0, after printing
Film be put into drying box, 37 DEG C of dryings 6 hours are subsequently placed in preserve in the hermetic bag containing drier and used.
It is prepared by polyclonal antibody die:With experiment one.
Semi-finished product assemble method:With experiment one.
Experimental group:The test strips of above-mentioned preparation are taken, with the side of polystyrene microsphere mark adsorbed film upward, are placed in centrifugation
In machine rotor, to polystyrene microsphere mark adsorbed film on be added dropwise preparation various concentrations human muscle hemoglobin solution 80ul, it is quiet
Put 2 minutes, centrifuged 1 minute with 1000 revs/min, then 0.05% tween to dropwise addition pH7.4 on polystyrene microsphere mark adsorbed film
20th, 50mM PBSs 80ul, 2000 revs/min of centrifugations are cleaned for 30 seconds, and cleaning twice, takes out test strips, cuts Anti-TNF-α
Body die detection line, is positioned in cuvette, adds West Pico chemiluminescence detection substrates, 5 minutes is stood, in chemistry
6 seconds luminous quantities are read on luminometer, experiment in triplicate, results averaged, then draws concentration-luminosity curve, and
Calculate coefficient correlation.
3rd, experimental result
The present invention is tested using polystyrene microsphere as liquid phase reactor delivery vehicle using methods described A, observes different-grain diameter
Influence to experimental result.As a result, particle diameter of the present invention be 45,201,376,600,1000nm detection data are in well dense
The dependency relation of degree-luminous value, correlation coefficient r are all higher than 0.99, illustrate that the particulate of different-grain diameter is applied to the technology of the present invention.It is real
It is as shown in table 8 to test result.
Influence of 8 diameter of particle of the present invention of table to testing result(Unit:Luminous value)
Experiment nine, the comparative experiments of linear detection range of the present invention and existing detection technique
First, experiment material
Fluorescent microsphere(The biology of Shanghai outstanding person one), trehalose(SIGMA), nitrocellulose filter(Millipore companies), EDC
(PIERCE companies), NHS(PIERCE companies), magnetic particle(Zhengzhou English promise biology), quantitative fluorescence analysis instrument(Shanghai woman biology
Company, HG-98), the quantitative chromatographic analysis instrument of collaurum(Norway's Skannex products), it is other with experiment one.
Above-mentioned material corresponds to that Patent Application Request content is as follows, and this experimental fluorescence microballoon is particulate, other with experiment one.
2nd, experimental method
1st, the preparation of human muscle hemoglobin solution:The human muscle hemoglobin solution of concentration known is taken, uses sample dilution buffer(1%BSA,
100mM glycine, 50mM PBS, 150mM NaCl, pH7.4)Dilution configuration 1000ng/ml human muscle hemoglobin solution.
2nd, existing colloidal gold method immunoassay technology group:
Colloidal gold particles mark:With experiment two.
Colloidal gold particles mark absorption film preparation:With experiment one.
It is prepared by polyclonal antibody die:With experiment one.
Semi-finished product assemble method:With experiment one.
The test strips of above-mentioned preparation are taken, are placed in desktop, is marked to colloidal gold particles and the different dense of preparation is added dropwise on adsorbed film
The human muscle hemoglobin solution 80ul of degree, 20 minutes are stood, be positioned on the quantitative chromatographic analysis instrument of collaurum and read polyclonal antibody
The digital picture of trace band, carry out image procossing and obtain corresponding chroma value.Test in triplicate, results averaged.
Control experiment is using the Liquid sample introduction for not containing myoglobins.Calculate group containing human muscle hemoglobin and the ratio without human muscle hemoglobin group
Value.
3rd, existing chemiluminescence detection technology group:It is polyclonal with the anti-human myoglobins of 1mg/ml using conventional labels method
Magnetic particle is marked antibody, the amount ratio of anti-human myoglobins polyclonal antibody and magnetic particle(w/w)For 3:1;Using NHS
The anti-human myoglobins monoclonal antibody of horseradish peroxidase-labeled of activation.EP is taken to manage, often pipe is added with anti-human myoglobins
The μ l of magnetic particle 100 of polyclonal antibody mark, then it is separately added into each 100 μ l of human muscle hemoglobin solution that concentration is 1 μ g/ml, knot
Close reaction and incubation is shaked at 37 DEG C 60 minutes, with magnetic separator adsorbing separation magnetic particle, abandon supernatant, add the μ l of PBS 200 cleanings
Three times, with magnetic separator adsorbing separation magnetic particle, supernatant is abandoned, adds the anti-human myoglobins monoclonal of horseradish peroxidase-labeled
The μ l of antibody 200, association reaction are shaked at 37 DEG C and incubated with the corresponding reaction time, micro- with magnetic separator adsorbing separation magnetic
Grain, supernatant is abandoned, add the μ l of PBS 200 cleanings three times, with magnetic separator adsorbing separation magnetic particle, abandon supernatant, transfer magnetic particle is extremely
In cuvette, chemiluminescence detector is put, adds 100 μ l luminous substrate working solutions, when reaction is carried out 5 minutes, record is luminous
Amount 6 seconds.Control experiment is using the Liquid sample introduction for not containing myoglobins.Calculate group containing human muscle hemoglobin and be free of people's flesh red eggs
The ratio organized in vain.
4th, existing fluorescence immunoassay detection technique group:
Fluorescent microsphere marks:Take 0.5ml microballoons, using pH7.2 0.1M phosphate buffers eccentric cleaning 4 times, 13000rpm from
The heart, redissolved with pH7.2 0.1M phosphate buffers to 1ml, add the anti-human myoglobins monoclonal antibodies of 200 μ g, mixed, its
It is the same as experiment five.
Fluorescent microsphere mark absorption film preparation:With experiment five.
It is prepared by polyclonal antibody die:With experiment one.
Semi-finished product assemble method:With experiment one.
The test strips of above-mentioned preparation are taken, are placed in desktop, the various concentrations that preparation is added dropwise on adsorbed film are marked to fluorescent microsphere
Human muscle hemoglobin solution 80ul, stand 20 minutes, be positioned on quantitative fluorescence analysis instrument reading polyclonal antibody trace band
Fluorescent value.Test in triplicate, results averaged.Control experiment is using the Liquid sample introduction for not containing myoglobins.Calculate
Group containing human muscle hemoglobin and the ratio without human muscle hemoglobin group.
5th, detection technique group of the present invention:
Colloidal gold particles mark:With experiment one.
Colloidal gold particles mark absorption film preparation:With experiment one.
It is prepared by polyclonal antibody die:With experiment one.
Semi-finished product assemble method:With experiment one.
The test strips of above-mentioned preparation are taken, with the side of colloidal gold particles mark adsorbed film upward, are placed in centrifuge rotor,
The human muscle hemoglobin solution 80ul of the various concentrations of preparation is added dropwise on to colloidal gold particles mark adsorbed film, stands 2 minutes, with
1000 revs/min centrifuge 1 minute, then 0.05% Tween-20,50mM PBS to dropwise addition pH7.4 on colloidal gold particles mark adsorbed film
Buffer solution 80ul, 2000 revs/min of centrifugations are cleaned for 30 seconds, and cleaning twice, takes out test strips, cuts the detection of polyclonal antibody die
Line, it is positioned in cuvette, adds West Pico chemiluminescence detection substrates, 5 minutes is stood, in chemiluminescence detector
6 seconds luminous quantities of upper reading, test in triplicate, results averaged.Control experiment is entered using the liquid for not containing myoglobins
Sample.Calculate group containing human muscle hemoglobin and the ratio without human muscle hemoglobin group.
3rd, experimental result
The present invention is tested using colloidal gold particles as liquid phase reactor delivery vehicle using methods described A, and other groups using existing
Conventional method.As a result human muscle hemoglobin 1000ng groups and without human muscle hemoglobin group ratio be respectively 37 times of collaurum, it is glimmering
Light is immune 74 times, 185 times of chemiluminescence, 437 times of the present invention, it is linear to illustrate that the technology of the present invention significantly improves existing detection technique
Detection interval, improve sensitivity and the accuracy of detection.Experimental result is as shown in table 9.
The comparative experiments of 9 linear detection range of the present invention of table and existing detection technique
**p<0.01
Experiment ten, the of the invention and comparison of existing chemiluminescence detection technology testing result
First, experiment material
Magnetic particle(Zhengzhou English promise biology), it is other with experiment one.
2nd, experimental method
Make standard curve:Take concentration known human muscle hemoglobin solution 3.125,6.25,12.5,25,50,100ng/ml people's flesh
Hemoglobin solution, of the invention and existing chemiluminescence detection technology is respectively adopted and detects and draws standard curve.With concentration known
Human muscle hemoglobin 10ng/ml as sample to be checked.
Existing chemiluminescence detection technology group:With experiment nine, reference standard curve calculates sample myoglobin concentration to be checked.
Detection technique group of the present invention:With experiment one, reference standard curve calculates sample myoglobin concentration to be checked.
3rd, experimental result
The concrete outcome for repeating experiment three times is as shown in table 10.Existing chemiluminescence detection technology measurement result shows sample to be checked
The content of human muscle hemoglobin is 9.76ng/ml, and measurement result of the present invention shows that the content of sample human muscle hemoglobin to be checked is
10.43ng/ml, two kinds of experimental method acquired results are basically identical, no difference of science of statistics(P>0.05), but the completion of the present invention is real
Testing the time is significantly shorter than current art.
Table 10 is of the invention with the comparison of existing chemiluminescence detection technology testing result(Unit:ng/ml)
Repeat 1 | Repeat 2 | Repeat 3 | Average value | |
Current art | 9.67 | 9.09 | 10.53 | 9.76 |
The present invention | 9.88 | 10.54 | 10.89 | 10.43 |
Test 11, the of the invention and comparison of existing Immunofluorescence test technology for detection result
First, experiment material
Fluorescent microsphere(Fluorescein used is europium compound, and Shanghai outstanding person one is biological), trehalose(SIGMA), EDC(PIERCE is public
Department), NHS(PIERCE companies), sheep anti-mouse igg polyclonal antibody(Genagates companies of the U.S.), quantitative fluorescence analysis instrument(On
Extra large woman biotech firm, HG-98), it is other with experiment one.
2nd, experimental method
1st, standard curve is made:Take concentration known human muscle hemoglobin solution 3.125,6.25,12.5,25,50,100ng/ml people
Myoglobin solution, of the invention and existing fluorescence immunoassay detection technique is respectively adopted and detects and draws standard curve.With known dense
The human muscle hemoglobin 10ng/ml of degree is as sample to be checked.
2nd, existing fluorescence immunoassay detection technique group:
Fluorescent microsphere marks:Take 0.5ml microballoons, using pH7.2 0.1M phosphate buffers eccentric cleaning 4 times, 13000rpm from
The heart, redissolved with pH7.2 0.1M phosphate buffers to 1ml, add the anti-human myoglobins monoclonal antibodies of 200 μ g, mixed, its
It is the same as experiment five.
Fluorescent microsphere mark absorption film preparation:With experiment five.
It is prepared by polyclonal antibody die:According to the antibody die method of experiment one sheep anti mouse is printed in the distal end of immobilon-p
IgG polyclonal antibodies, as nature controlling line(C lines), anti-human myoglobins polyclonal antibody is printed in the proximal part of immobilon-p, as
Detection line(T lines), it is other with experiment one.
Semi-finished product assemble method:Fluorescent labeled antibody adsorbed film is pasted on tip side, and absorbing membrane pad is pasted on C line sides, other
With experiment one.
The test strips of above-mentioned preparation are taken, are placed in desktop, the various concentrations that preparation is added dropwise on adsorbed film are marked to fluorescent microsphere
Human muscle hemoglobin solution 80ul, stand 20 minutes, be placed on quantitative fluorescence analysis instrument read polyclonal antibody printed film on
Detection line T and nature controlling line C fluorescent value, and T/C ratios are calculated, standard curve is drawn, calculates measuring samples myoglobin concentration.
3rd, detection technique group of the present invention:
Fluorescent microsphere marks:Take 0.5ml microballoons, using pH7.2 0.1M phosphate buffers eccentric cleaning 4 times, 13000rpm from
The heart, redissolved with pH7.2 0.1M phosphate buffers to 1ml, add the anti-human myoglobins monoclonal antibodies of 200 μ g, horseradish peroxide
Change the μ g of enzyme 200, mix, it is other with experiment five.
Fluorescent microsphere mark absorption film preparation:With experiment five.
It is prepared by polyclonal antibody die:With experiment one.
Semi-finished product assemble method:With experiment one.
The test strips of above-mentioned preparation are taken, with the side of fluorescent microsphere labelled antibody adsorbed film upward, are placed in centrifuge rotor
It is interior, to fluorescent microsphere labelled antibody adsorbed film on be added dropwise preparation various concentrations human muscle hemoglobin solution and testing sample it is each
80ul, 2 minutes are stood, 1000 revs/min centrifuge 1 minute, then to being added dropwise pH7.4's on fluorescent microsphere labelled antibody adsorbed film
0.05% Tween-20,50mM PBSs 80ul, 2000 revs/min of centrifugations are cleaned for 30 seconds, and repeated washing once, takes out test paper
Bar, polyclonal antibody die detection line is cut, is positioned in cuvette, add West Pico chemiluminescence detection substrates, it is quiet
Put 5 minutes, 6 seconds luminous quantities are read on chemiluminescence detector, test in triplicate, results averaged, reference standard is bent
Line computation sample myoglobin concentration to be checked.
3rd, experimental result
For the technology of the present invention through operating as above, standard curve is linearly good, and correlation coefficient r value is 0.995, has carried out sample survey immediately
Fixed, the ng/ml of empirical average 10.36, detection error meet the requirements within 10% three times.Determined using prior art, after point sample
20 minutes of existing Product checking are stood, standard curve is linearly good, and correlation coefficient r value is 0.989, immediately according to 20 minutes
Condition has carried out sample measure, and average value is 9.13ng/ml three times, and detection error meets the requirements within 10%.Repeat three times
The concrete outcome of experiment is as shown in table 11.Compared with the prior art, the present invention significantly shorten detection time.
The Analysis of test results of the present invention of table 11 and Immunofluorescence test technology(Unit:ng/ml)
Repeat 1 | Repeat 2 | Repeat 3 | Average value | |
The present invention | 10.73 | 10.53 | 9.81 | 10.36 |
Prior art | 10.26 | 8.29 | 8.86 | 9.13 |
Test 12, the of the invention and comparison of existing enzyme linked immunosorbent detection technology for detection result
First, experiment material
Fluorescent microsphere(Fluorescein used is europium compound, and Shanghai outstanding person one is biological), trehalose(SIGMA), EDC(PIERCE is public
Department), NHS(PIERCE companies), enzyme-linked immunosorbent assay instrument(Bio-Rad, Model 550), horseradish peroxidase-labeled goat-anti
Mouse IgG polyclonal antibodies(Genagates companies of the U.S. provide), it is other with experiment one.
2nd, experimental method
The preparation of human muscle hemoglobin solution:Take the human muscle hemoglobin solution of concentration known, with PBS solution configuration 3.125,6.25,
12.5th, 25,50,100 ng/ml serial human muscle hemoglobin solution, is respectively adopted of the invention and existing enzyme linked immunosorbent detection technology
Detect and draw standard curve.Sample to be checked is used as using the human muscle hemoglobin 10ng/ml of concentration known.
1st, existing enzyme linked immunosorbent detection technology groups
Using 96 hole elisa plates, the anti-human μ l of myoglobins polyclonal antibody 100 of often pipe addition, 4 DEG C are coated with overnight, clean three times,
Human muscle hemoglobin solution or the μ l of measuring samples 100 are separately added into again, and association reaction incubates 120 minutes at 37 DEG C, and cleaning three times, adds
Enter the anti-human μ l of myoglobins monoclonal antibody 100, association reaction incubates 60 minutes at 37 DEG C, and cleaning three times, abandons supernatant, adds peppery
The μ l of root peroxidase labelling sheep anti-mouse igg polyclonal antibody 100, association reaction are incubated 60 minutes at 37 DEG C, and cleaning three times, is abandoned
Supernatant, add 100 μ l nitrite ions(Formula:0.1M citric acids 2.43ml, 0.2M disodium hydrogen phosphate 2.57ml, o-phenylenediamine 5mg,
The μ l of hydrogen peroxide 5), lucifuge 5 minutes, add 2M sulfuric acid terminating reactions.Reading OD490 light absorption values on enzyme-linked immunosorbent assay instrument are put,
Reference standard curve, calculate human muscle hemoglobin content in sample to be checked.
2nd, of the present invention group
Fluorescent microsphere marks:With experiment 11.
Fluorescent microsphere mark absorption film preparation:With experiment five.
It is prepared by polyclonal antibody die:With experiment one.
Semi-finished product assemble method:With experiment one.
The test strips of above-mentioned preparation are taken, with the side of fluorescent microsphere labelled antibody adsorbed film upward, are placed in centrifuge rotor
It is interior, to fluorescent microsphere labelled antibody adsorbed film on be added dropwise preparation various concentrations human muscle hemoglobin solution and testing sample it is each
80ul, 2 minutes are stood, 1000 revs/min centrifuge 1 minute, then to being added dropwise pH7.4's on fluorescent microsphere labelled antibody adsorbed film
0.05% Tween-20,50mM PBSs 80ul, 2000 revs/min of centrifugations are cleaned for 30 seconds, and repeated washing once, takes out test paper
Bar, polyclonal antibody die detection line is cut, is positioned in cuvette, add West Pico chemiluminescence detection substrates, it is quiet
Put 5 minutes, 6 seconds luminous quantities are read on chemiluminescence detector, test in triplicate, results averaged, reference standard is bent
Line computation sample myoglobin concentration to be checked.
3rd, experimental result
Concrete outcome is as shown in table 12.Existing enzyme linked immunosorbent detection technology measurement result shows containing for sample human muscle hemoglobin to be checked
Measure and show that the content of sample human muscle hemoglobin to be checked is 10.34ng/ml for 9.83ng/ml, measurement result of the present invention, two kinds are tested
Method acquired results are basically identical, no difference of science of statistics(P>0.05), but the present invention completion experimental period be significantly shorter than it is existing
Technology.
Table 12 is of the invention with the comparison of existing enzyme linked immunosorbent detection technology for detection result(Unit:ng/ml)
Repeat 1 | Repeat 2 | Repeat 3 | Average value | |
Current art | 11.09 | 9.18 | 9.22 | 9.83 |
The present invention | 10.78 | 8.99 | 11.24 | 10.34 |
Test 13, the of the invention and comparison of the testing result of existing dot immune gold filtration assay
First, experiment material
The quantitative chromatographic analysis instrument of collaurum(Norway's Skannex products), it is other with experiment one.
2nd, experimental method
The preparation of human muscle hemoglobin solution:Take the human muscle hemoglobin solution of concentration known, with PBS solution configuration 3.125,6.25,
12.5th, 25,50,100 ng/ml serial human muscle hemoglobin solution, is respectively adopted of the invention and existing enzyme linked immunosorbent detection technology
Detect and draw standard curve.Sample to be checked is used as using the human muscle hemoglobin 10ng/ml of concentration known.
2nd, existing colloid gold immune detection technique group:
Colloidal gold particles mark:With experiment two.
Colloidal gold particles mark absorption film preparation:With experiment one.
It is prepared by polyclonal antibody die:According to the antibody die method of experiment one sheep anti mouse is printed in the distal end of immobilon-p
IgG polyclonal antibodies, as nature controlling line(C lines), anti-human myoglobins polyclonal antibody is printed in the proximal part of immobilon-p, as
Detection line(T lines), it is other with experiment one.
Semi-finished product assemble method:Colloidal gold particles labelled antibody adsorbed film is pasted on tip side, and absorbing membrane pad is pasted on C lines
Side, it is other with experiment one.
Semi-finished product assemble method:With experiment one.
The test strips of above-mentioned preparation are taken, are placed in desktop, is marked to colloidal gold particles and the different dense of preparation is added dropwise on adsorbed film
The human muscle hemoglobin solution 80ul of degree, 20 minutes are stood, be placed on the quantitative chromatographic analysis instrument of collaurum and read polyclonal antibody
Detection line T and nature controlling line C pattern colour angle value on printed film, and T/C ratios are calculated, standard curve is drawn, calculates measuring samples
Myoglobin concentration.
3rd, colloidal gold particles immunoassay technology group of the present invention:
Colloidal gold particles mark:With experiment one.
Colloidal gold particles mark absorption film preparation:With experiment one.
It is prepared by polyclonal antibody die:With experiment one.
Semi-finished product assemble method:With experiment one.
The test strips of above-mentioned preparation are taken, with the side of colloidal gold particles mark adsorbed film upward, are placed in centrifuge rotor,
The human muscle hemoglobin solution 80ul of the various concentrations of preparation is added dropwise on to colloidal gold particles mark adsorbed film, stands 2 minutes, with
1000 revs/min centrifuge 1 minute, then 0.05% Tween-20,50mM PBS to dropwise addition pH7.4 on colloidal gold particles mark adsorbed film
Buffer solution 80ul, 2000 revs/min of centrifugations are cleaned for 30 seconds, and cleaning twice, takes out test strips, cuts the detection of polyclonal antibody die
Line, it is positioned in cuvette, adds West Pico chemiluminescence detection substrates, 5 minutes is stood, in chemiluminescence detector
6 seconds luminous quantities of upper reading, in triplicate, results averaged, it is dense that reference standard curve calculates sample myoglobins to be checked for experiment
Degree.
3rd, experimental result
Concrete outcome is as shown in table 13.Existing colloid gold immune detection technique measurement result shows sample human muscle hemoglobin to be checked
Content is 9.63ng/ml, and measurement result of the present invention shows that the content of sample human muscle hemoglobin to be checked is 9.81ng/ml, two kinds of realities
Proved recipe method acquired results are basically identical, no difference of science of statistics(P>0.05), but the completion experimental period of the present invention is significantly shorter than now
Row technology.
Table 13 is of the invention with the comparison of existing colloid gold immune detection technique testing result(Unit:ng/ml)
Repeat 1 | Repeat 2 | Repeat 3 | Average value | |
Current art | 9.29 | 10.69 | 8.91 | 9.63 |
The present invention | 8.12 | 11.22 | 10.08 | 9.81 |
Test 14, influence of the cleaning step of the present invention to testing result
First, experiment material
With experiment one
2nd, experimental method
Sample not contain human muscle hemoglobin does not clean as sample to be checked, control, stands chromatography;Experiment is using 40,80,
120th, 160ul is cleaned, other with experiment one.
3rd, experimental result
Experimental result is as shown in table 14.Two test results compare, and cleaning can reduce non-spy of the chemiluminescence enzyme on immobilon-p
The opposite sex combines, and the effect of centrichromatography cleaning is especially pronounced, and 160ul cleanings, which have been down to immobilon-p background, can meet to test
It is required that light levels.It is necessary to illustrate to test after sample introduction with the step of cleaning, and eccentric cleaning is required.
Influence of 14 cleaning step of the present invention of table to testing result(Unit:Luminous value)
Centrifugation | Do not centrifuge | |
0 | 2135438 | 2891573 |
40 | 1234571 | 2354216 |
80 | 376525 | 1921574 |
120 | 63527 | 1251679 |
160 | 12761 | 1022138 |
Claims (13)
1. a kind of paper chromatography chemiluminescence detection combined complete, is characterised by, the detection combination suit is special containing thing to be checked
Property conjugate, particulate, immobilon-p, chemiluminescent reactant, centrifugal device and luminescence detector, wherein described chemiluminescence
Reactant includes at least one in chemiluminescence enzyme, chemiluminescent substance, chemiluminescence enzyme reaction substrate and starting luminescence reagent
Kind;The particulate is that can be formed directly and/or by chemical crosslinking mode and protein and/or the chemiluminescent reactant
Non-specific binding simultaneously maintains stable particle;The immobilon-p is with the film quality thing with protein non-specific binding characteristic
Matter;The centrifugal device is the structure that can centrifuge driving liquid phase chromatographic flow on the immobilon-p;The thing to be checked is special
Property conjugate be at least one of antigen with specific binding capacity, antibody, Avidin, biotin and the like.
2. the detection method that detection combination described in a kind of claim 1 is set with, it is characterised in that:The detection method is as follows
(A)-(F)In it is any:
(A)Comprise the following steps:
1)The particulate is marked with the thing specificity junction mixture to be checked and the chemiluminescence enzyme simultaneously;
2)Reacted with the particulate after the sample containing thing to be checked and the mark, the thing to be checked by with after the mark
Particulate on the thing specificity junction mixture to be checked combine, and then form " chemiluminescence enzyme-particulate-thing to be checked specificity knot
Compound-thing to be checked " compound, i.e. compound 1;
3)Coating can be treated by forming the second of specific binding with the thing to be checked on compound 1 on the immobilon-p
Examine thing specificity junction mixture;
4)With the liquid phase containing the compound 1, by chromatography, to flow through coated second thing to be checked on the immobilon-p special
Property conjugate, form " chemiluminescence enzyme-particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing to be checked specific binding
Thing " compound, i.e. compound 2, and be captured and be fixed on the immobilon-p;
5)Using centrifugal chromatography, cleaned with cleaning fluid described in the compound 1 being not associated with the immobilon-p and residual
Chemiluminescence enzyme;
6)The immobilon-p after cleaning is placed in the chemiluminescence enzyme reaction substrate liquid and reacted, and with the luminous detection
Chemiluminescence enzyme reaction substrate described in the chemiluminescence enzymatic that device detection is indirectly fixed on the immobilon-p produces
Luminous value, to detect the content of the thing to be checked;
(B)Comprise the following steps:
1)The particulate described in the thing specific binding substance markers to be checked;
2)The specificity junction mixture of the thing specificity junction mixture to be checked is marked with the chemiluminescence enzyme, forms " chemiluminescence
The specificity junction mixture of enzyme-thing to be checked specificity junction mixture ", i.e. chemiluminescence enzyme marker;
3)Reacted with the particulate after the sample containing thing to be checked and the mark, the thing to be checked by with after the mark
Particulate on the thing specificity junction mixture to be checked combine, and then form " particulate-thing to be checked specificity junction mixture-thing to be checked "
Compound, i.e. compound 3;
4)The described second thing specificity junction mixture to be checked is coated with the immobilon-p;
5)With the liquid phase containing the compound 3, by chromatography, to flow through coated second thing to be checked on the immobilon-p special
Property conjugate, formed " particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing specificity junction mixture to be checked " compound, i.e.,
Compound 4, and be captured and be fixed on the immobilon-p;
6)With the liquid phase containing the chemiluminescence enzyme marker by chromatography flow through be trapped in it is compound on the immobilon-p
Thing 4, by being combined with the thing specificity junction mixture to be checked, formed " the chemiluminescence enzyme marker-compound of compound 4 ", i.e.,
Compound 5, and be captured and be fixed on the immobilon-p;
6)Using centrifugal chromatography, the chemiluminescence enzyme marker that is not associated with the immobilon-p and residual is cleaned with cleaning fluid
The chemiluminescence enzyme stayed;
7)The immobilon-p after cleaning is placed in the chemiluminescence enzyme reaction substrate liquid and reacted, and with the luminous detection
The chemiluminescence enzyme reaction substrate described in the chemiluminescence enzymatic that device detection is indirectly fixed on the immobilon-p
Caused luminous value, to detect the content of the thing to be checked;
(C)Comprise the following steps:
1)The particulate is marked with the thing specificity junction mixture to be checked and the chemiluminescence enzyme simultaneously;
2)Reacted with the particulate after the sample containing thing to be checked and the mark, the thing to be checked by with after the mark
Particulate on the thing specificity junction mixture to be checked combine, the thing to be checked by with the thing specificity junction mixture knot to be checked
Close, and then form " chemiluminescence enzyme-particulate-thing to be checked specificity junction mixture-thing to be checked " compound, i.e., described compound 1;
3)The second thing specificity junction mixture to be checked is marked with intermediate material A;
4)Coating can form the intermediate material B of specific binding with the intermediate material A on the immobilon-p;
5)The the second thing specificity junction mixture to be checked marked with the liquid phase containing the compound 1 with the intermediate material A is carried out
Reaction, formed " chemiluminescence enzyme-particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing specificity junction mixture to be checked-in
Between substance A " compound, i.e. compound 6;
6)The coated intermediate material B on the immobilon-p is flowed through by chromatography with the liquid phase containing the compound 6, formed
" chemiluminescence enzyme-particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing specificity junction mixture-intermediate material A- to be checked
Intermediate material B " compounds, i.e. compound 7, and be captured and be fixed on the immobilon-p;
7)Using centrifugal chromatography, cleaned with cleaning fluid described in the compound 6 being not associated with the immobilon-p and residual
Chemiluminescence enzyme;
8)The immobilon-p after cleaning is placed in the chemiluminescence enzyme reaction substrate liquid and reacted, and with the luminous detection
Chemiluminescence enzyme reaction substrate described in the chemiluminescence enzymatic that device detection is indirectly fixed on the immobilon-p produces
Luminous value, to detect the content of the thing to be checked;
(D)Comprise the following steps:
1)The particulate described in the thing specific binding substance markers to be checked;
2)The specificity junction mixture of the thing specificity junction mixture to be checked is marked with the chemiluminescence enzyme, forms " chemiluminescence
The specificity junction mixture of enzyme-thing to be checked specificity junction mixture ", i.e., described chemiluminescence enzyme marker;
3)Reacted with the particulate after the sample containing thing to be checked and the mark, the thing to be checked by with after the mark
Particulate on the thing specificity junction mixture to be checked combine, and then form " particulate-thing to be checked specificity junction mixture-thing to be checked "
Compound, i.e., described compound 3;
4)The second thing specificity junction mixture to be checked is marked with the intermediate material A;
5)Coating can form the intermediate material B of specific binding with the intermediate material A on the immobilon-p;
6)Reacted with the second thing specificity junction mixture to be checked of the liquid phase containing the compound 3 and intermediate material A marks,
Formed " particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing specificity junction mixture to be checked-intermediate material A " compounds,
That is compound 8;
7)The coated intermediate material B on the immobilon-p is flowed through by chromatography with the liquid phase containing the compound 8, formed
" particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing specificity junction mixture to be checked-intermediate material A- intermediate materials B " is multiple
Compound, i.e. compound 9, and be captured and be fixed on the immobilon-p;
8)With the liquid phase containing the chemiluminescence enzyme marker by chromatography flow through be trapped in it is compound on the immobilon-p
Thing 9, by being combined with thing specificity junction mixture to be checked, form " the specificity knot of chemiluminescence enzyme-thing to be checked specificity junction mixture
Compound-the compound of compound 9 ", i.e. compound 10, and be captured and be fixed on the immobilon-p;
9)Using centrifugal chromatography, the chemiluminescence enzyme marker that is not associated with the immobilon-p and residual is cleaned with cleaning fluid
The chemiluminescence enzyme stayed;
10)The immobilon-p after cleaning is placed in chemiluminescence enzyme reaction substrate liquid and reacted, and with the luminescence detector
Detect and lighted caused by chemiluminescence enzyme reaction substrate described in the chemiluminescence enzymatic being indirectly fixed on the immobilon-p
Value, to detect the content of the thing to be checked;
(E)Comprise the following steps:
1)The thing specificity junction mixture to be checked and chemiluminescent substance mark are connected on the particulate;
2)Reacted with the particulate after the sample containing thing to be checked and the mark, the thing to be checked by with after the mark
Particulate on the thing specificity junction mixture to be checked combine, and then form " chemiluminescent substance-particulate-thing to be checked specificity
Conjugate-thing to be checked " compound, i.e. compound 11;
3)The second thing specificity junction mixture to be checked is coated with the immobilon-p;
4)The coated second thing spy to be checked on the immobilon-p is flowed through by chromatography with the liquid phase containing the compound 11
Specific binding agent, form " chemiluminescent substance-particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing specificity to be checked
Conjugate " compound, i.e. compound 12, and be captured and be fixed on the immobilon-p;
5)Using centrifugal chromatography, described in cleaning fluid cleans the compound 11 being not associated with the immobilon-p and residual
Chemiluminescent substance;
6)The immobilon-p after cleaning is placed in the starting luminescence reagent solution and reacted, and is examined with the luminescence detector
Luminous value caused by the chemiluminescent substance decomposition being indirectly fixed on the immobilon-p is surveyed, to detect the thing to be checked
Content;
(F)Comprise the following steps:
1)The particulate described in the thing specific binding substance markers to be checked;
2)The specificity junction mixture of the thing specificity junction mixture to be checked is marked with the chemiluminescent substance, forms " chemistry hair
The specificity junction mixture of stimulative substance-thing to be checked specificity junction mixture ", i.e. chemiluminescent substance label;
3)Reacted with the particulate after the sample containing thing to be checked and the mark, the thing to be checked by with after the mark
Particulate on the thing specificity junction mixture to be checked combine, and then form " particulate-thing to be checked specificity junction mixture-thing to be checked "
Compound, i.e., described compound 3;
4)The second thing specificity junction mixture to be checked is coated with the immobilon-p;
5)With the liquid phase containing the compound 3, by chromatography, to flow through coated second thing to be checked on the immobilon-p special
Property conjugate, formed " particulate-thing to be checked specificity junction mixture-thing-the second to be checked thing specificity junction mixture to be checked " compound, i.e.,
The compound 4, and be captured and be fixed on the immobilon-p;
6)With the liquid phase containing chemiluminescent substance label by chromatography flow through be trapped in it is described multiple on the immobilon-p
Compound 4, by being combined with the thing specificity junction mixture to be checked, form " chemiluminescent substance-thing to be checked specificity junction mixture
Specificity junction mixture-the compound of compound 4 ", i.e. compound 13, and be captured and be fixed on the immobilon-p;
6)Using centrifugal chromatography, cleaned with cleaning fluid the chemiluminescent substance label that is not associated with the immobilon-p and
The chemiluminescent substance of residual;
7)The immobilon-p after cleaning is placed in the starting luminescence reagent and reacted, and quilt is detected with the luminescence detector
Luminous value caused by the chemiluminescent substance decomposition on the immobilon-p is indirectly fixed to, to detect the content of the thing to be checked.
3. detection method according to claim 2, it is characterised in that:The intermediate material is with specific binding capacity
Antigen, antibody, Avidin, at least one of biotin and the like.
4. detection method according to claim 2, it is characterised in that:The reaction that the chromatography flows through the immobilon-p exists
Completed on centrifugal device and using centrifugal chromatography driving liquid chromatographic flow on immobilon-p.
5. the detection method described in combined complete according to claim 1 or claim 2, it is characterised in that:It is described micro-
The particle diameter selection 1nm-10um of grain.
6. detection combination suit according to claim 1, it is characterised in that:The rotating speed of the centrifugal device uses program control
Mode processed;The rotating speed of the centrifugal device is 200 ~ 10000 revs/min.
7. detection method according to claim 2, it is characterised in that:The rotating speed of the centrifugal chromatography uses programme-control
Mode;The rotating speed of the centrichromatography is 200 ~ 10000 revs/min.
8. the detection method described in combined complete according to claim 1 or claim 2, it is characterised in that:Describedization
Learning Luminescence Enzyme includes at least one of HRPO, alkaline phosphatase and xanthine oxidase.
9. the detection method described in combined complete according to claim 1 or claim 2 or 4, it is characterised in that:It is described
Immobilon-p includes nitrocellulose filter, polyvinylidene fluoride film, nylon membrane, DEAE cellulose membranes;The detector is chemiluminescence
Detector.
10. detection combination suit according to claim 1, it is characterised in that:The detection combination suit is also comprising
Cleaning fluid is stated, the cleaning fluid is the normal experiment cushioning liquid containing surfactant.
11. detection method according to claim 2, it is characterised in that:The cleaning fluid is to contain the normal of surfactant
Advise experiment cushioning liquid.
12. detection combination suit according to claim 1, it is characterised in that:Detection combination suit also includes the
Two thing specificity junction mixtures to be checked, intermediate material A, intermediate material B, thing specificity junction mixture to be checked specificity junction mixture in
It is at least one.
13. the answering in immune detection product development of the combined complete or detection method any one of claim 1-12
With.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610373048.6A CN107449906A (en) | 2016-05-31 | 2016-05-31 | A kind of paper chromatography chemical luminescence detection method |
PCT/CN2017/086044 WO2017206800A1 (en) | 2016-05-31 | 2017-05-26 | Centrifugal chromatography immunoassay method |
US16/206,726 US20190170735A1 (en) | 2016-05-31 | 2018-11-30 | Immuno chromatography method with centrifuge isolation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610373048.6A CN107449906A (en) | 2016-05-31 | 2016-05-31 | A kind of paper chromatography chemical luminescence detection method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107449906A true CN107449906A (en) | 2017-12-08 |
Family
ID=60485733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610373048.6A Pending CN107449906A (en) | 2016-05-31 | 2016-05-31 | A kind of paper chromatography chemical luminescence detection method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107449906A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107525923A (en) * | 2017-04-01 | 2017-12-29 | 北京康华源科技发展有限公司 | One kind centrifuges immunochromatography detection method and device |
CN108519373A (en) * | 2018-04-27 | 2018-09-11 | 广州万孚生物技术股份有限公司 | A kind of chemiluminescence micro-fluidic chip and the analytical instrument containing it |
CN110736737A (en) * | 2018-07-18 | 2020-01-31 | 博阳生物科技(上海)有限公司 | microsphere composition for chemiluminescence detection and application thereof |
CN113358621A (en) * | 2021-06-10 | 2021-09-07 | 姚杰 | Coaxial optical fiber fluorescence gene detection device and detection method thereof |
CN113504363A (en) * | 2021-04-20 | 2021-10-15 | 苏州有诺真生物科技有限公司 | Method for improving lateral chromatography sensitivity based on enzyme catalysis method |
CN114280289A (en) * | 2021-12-20 | 2022-04-05 | 南京诺唯赞医疗科技有限公司 | Magnetic particle chemiluminescence detection kit and detection method thereof |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009039239A2 (en) * | 2007-09-18 | 2009-03-26 | Idexx Laboratories, Inc. | Lateral flow assay using centrifugal force |
CN101520454A (en) * | 2008-02-04 | 2009-09-02 | 深圳微点生物技术有限公司 | Centrifugal fluid analyzer rotor |
US20130302830A1 (en) * | 2010-06-17 | 2013-11-14 | Rajesh K. Mehra | Rotors for immunoassays |
CN104076140A (en) * | 2014-07-09 | 2014-10-01 | 国家纳米科学中心 | Construction and application of chemiluminiscence-colloidal gold immunochromatography test paper |
CN204422537U (en) * | 2015-02-13 | 2015-06-24 | 南京天纵易康生物科技有限公司 | With the immunochromatographiassays assays instrument of centrifugal device |
CN105353159A (en) * | 2014-08-20 | 2016-02-24 | 余波 | Microfluidic test device and method for operating the same |
-
2016
- 2016-05-31 CN CN201610373048.6A patent/CN107449906A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009039239A2 (en) * | 2007-09-18 | 2009-03-26 | Idexx Laboratories, Inc. | Lateral flow assay using centrifugal force |
CN101520454A (en) * | 2008-02-04 | 2009-09-02 | 深圳微点生物技术有限公司 | Centrifugal fluid analyzer rotor |
US20130302830A1 (en) * | 2010-06-17 | 2013-11-14 | Rajesh K. Mehra | Rotors for immunoassays |
CN104076140A (en) * | 2014-07-09 | 2014-10-01 | 国家纳米科学中心 | Construction and application of chemiluminiscence-colloidal gold immunochromatography test paper |
CN105353159A (en) * | 2014-08-20 | 2016-02-24 | 余波 | Microfluidic test device and method for operating the same |
CN204422537U (en) * | 2015-02-13 | 2015-06-24 | 南京天纵易康生物科技有限公司 | With the immunochromatographiassays assays instrument of centrifugal device |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107525923A (en) * | 2017-04-01 | 2017-12-29 | 北京康华源科技发展有限公司 | One kind centrifuges immunochromatography detection method and device |
CN108519373A (en) * | 2018-04-27 | 2018-09-11 | 广州万孚生物技术股份有限公司 | A kind of chemiluminescence micro-fluidic chip and the analytical instrument containing it |
CN108519373B (en) * | 2018-04-27 | 2024-03-15 | 广州万孚生物技术股份有限公司 | Chemiluminescence micro-fluidic chip and analysis instrument comprising same |
CN110736737A (en) * | 2018-07-18 | 2020-01-31 | 博阳生物科技(上海)有限公司 | microsphere composition for chemiluminescence detection and application thereof |
CN113504363A (en) * | 2021-04-20 | 2021-10-15 | 苏州有诺真生物科技有限公司 | Method for improving lateral chromatography sensitivity based on enzyme catalysis method |
CN113358621A (en) * | 2021-06-10 | 2021-09-07 | 姚杰 | Coaxial optical fiber fluorescence gene detection device and detection method thereof |
CN114280289A (en) * | 2021-12-20 | 2022-04-05 | 南京诺唯赞医疗科技有限公司 | Magnetic particle chemiluminescence detection kit and detection method thereof |
CN114280289B (en) * | 2021-12-20 | 2023-10-10 | 南京诺唯赞医疗科技有限公司 | Magnetic particle chemiluminescence detection kit and detection method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107449906A (en) | A kind of paper chromatography chemical luminescence detection method | |
JP4758341B2 (en) | Chromatographic detector, inspection method and kit using the same | |
JP4934147B2 (en) | Test equipment for rapid diagnosis | |
WO2017206800A1 (en) | Centrifugal chromatography immunoassay method | |
JPH0312705B2 (en) | ||
CN106324243A (en) | Colloidal gold immunochromatography test strip and preparing and use method thereof | |
JPS6071957A (en) | Method of promoting immune reaction by ultrasonic treatment | |
CN107525923A (en) | One kind centrifuges immunochromatography detection method and device | |
CN105195243B (en) | The magnetic microparticle chemiluminescence micro-fluidic chip that a kind of myoglobins is quantitatively detected | |
EP0126772A1 (en) | Chromogenic support immunoassay | |
US20180364227A1 (en) | Detection method with centrifuge isolation and detection device thereof | |
CN102411051A (en) | Immunodetection method for organophosphorus pesticide multi-residue | |
CN102135541A (en) | Detection method of enterobacter sakazakii and gold-labeled rapid diagnosis kit for same and preparation method thereof | |
CN107192819A (en) | One kind centrifuges detection method | |
WO2018177445A1 (en) | Centrifugation immunochromatography detection method and apparatus | |
JP5388462B2 (en) | Carrier and production method thereof | |
CN107543922A (en) | A kind of centrichromatography fluorescence immunoassay detection technique and application thereof | |
JP2003215126A (en) | Method for extracting microbe antigen | |
JP6605802B2 (en) | Microorganism detection method by immunoassay, sample treatment method for immunoassay, sample pretreatment solution for immunoassay, and immunochromatography test kit | |
Yu et al. | Development of a magnetic microplate chemifluorimmunoassay for rapid detection of bacteria and toxin in blood | |
CN107727850A (en) | A kind of lateral flow chromatography detection reaction starts control method | |
CN105510574B (en) | Fluorescent nano probe and preparation method thereof and the method for the synchronous detection of Hazard factors a variety of in food | |
CN102331500A (en) | Method and enzyme linked immunosorbent assay kit for detecting lemon yellow | |
CN102854319A (en) | Kit for detection of drug residue in food and use method thereof | |
CN107561281A (en) | A kind of centrichromatography colloid gold immune detection technique and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20171208 |